Uncoupling	O
activation-dependent	O
HS1	B-protein
phosphorylation	O
from	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
transcriptional	O
activation	O
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
:	O
differential	O
signaling	O
through	O
CD3	B-protein
and	O
the	O
costimulatory	O
receptors	O
CD2	B-protein
and	O
CD28	B-protein
.	O

CD3	B-protein
,	O
CD2	B-protein
,	O
and	O
CD28	B-protein
are	O
functionally	O
distinct	O
receptors	O
on	O
T	B-cell_type
lymphocytes	I-cell_type
.	O

Engagement	O
of	O
any	O
of	O
these	O
receptors	O
induces	O
the	O
rapid	O
tyrosine	O
phosphorylation	O
of	O
a	O
shared	O
group	O
of	O
intracellular	B-protein
signaling	I-protein
proteins	I-protein
,	O
including	O
Vav	B-protein
,	O
Cbl	B-protein
,	O
p85	B-protein
phosphoinositide	I-protein
3-kinase	I-protein
,	O
and	O
the	O
Src	B-protein
family	I-protein
kinases	I-protein
Lck	B-protein
and	O
Fyn	B-protein
.	O

Ligation	O
of	O
CD3	B-protein
also	O
induces	O
the	O
tyrosine	O
phosphorylation	O
of	O
HS1	B-protein
,	O
a	O
75-kDa	B-protein
hematopoietic	I-protein
cell-specific	I-protein
intracellular	I-protein
signaling	I-protein
protein	I-protein
of	O
unknown	O
function	O
.	O

We	O
have	O
examined	O
changes	O
in	O
HS1	B-protein
phosphorylation	O
after	O
differential	O
stimulation	O
of	O
CD3	B-protein
,	O
CD2	B-protein
,	O
and	O
CD28	B-protein
to	O
elucidate	O
its	O
role	O
in	O
T	B-cell_type
cells	I-cell_type
and	O
to	O
further	O
delineate	O
the	O
signaling	O
pathways	O
recruited	O
by	O
these	O
receptors	O
.	O

Unlike	O
ligation	O
of	O
CD3	B-protein
,	O
stimulation	O
with	O
anti-CD28	B-protein
mAb	I-protein
or	O
CHO	B-cell_line
cells	I-cell_line
expressing	O
the	O
CD28	B-protein
ligands	I-protein
CD80	B-protein
or	O
CD86	B-protein
did	O
not	O
lead	O
to	O
tyrosine	O
phosphorylation	O
of	O
HS1	B-protein
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
.	O

Additionally	O
,	O
no	O
tyrosine	O
phosphorylation	O
of	O
HS1	B-protein
was	O
induced	O
by	O
mitogenic	B-cell_type
pairs	I-cell_type
of	O
anti-CD2	B-protein
mAbs	I-protein
capable	O
of	O
activating	O
the	O
transcription	B-protein
factor	I-protein
NFAT	I-protein
(	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
)	O
.	O

Costimulation	O
through	O
CD28	B-protein
and/or	O
CD2	B-protein
did	O
not	O
modulate	O
the	O
CD3	B-protein
-dependent	O
phosphorylation	O
of	O
HS1	B-protein
.	O

In	O
vivo	O
studies	O
indicated	O
that	O
CD3	B-protein
-induced	O
HSI	B-protein
phosphorylation	O
was	O
dependent	O
upon	O
both	O
the	O
Src	B-protein
family	I-protein
tyrosine	I-protein
kinase	I-protein
Lck	B-protein
and	O
the	O
tyrosine	B-protein
phosphatase	I-protein
CD45	B-protein
,	O
did	O
not	O
require	O
MEK1	B-protein
kinase	O
activity	O
,	O
and	O
was	O
regulated	O
by	O
protein	B-protein
kinase	I-protein
C	I-protein
activation	O
.	O

Thus	O
,	O
although	O
CD3	B-protein
,	O
CD28	B-protein
,	O
and	O
CD2	O
activate	O
many	O
of	O
the	O
same	O
signaling	B-protein
molecules	I-protein
,	O
they	O
differed	O
in	O
their	O
capacity	O
to	O
induce	O
the	O
tyrosine	O
phosphorylation	O
of	O
HSI	B-protein
.	O

Furthermore	O
,	O
activation-dependent	O
tyrosine	O
phosphorylation	O
of	O
HS1	B-protein
was	O
not	O
required	O
for	O
NFAT	B-protein
transcriptional	O
activation	O
.	O

K	NULL
Boldly	NULL
GolnVivo	NULL
``	NULL
``	NULL
BioLegend®	NULL
#	NULL
s	NULL
me	NULL
Journal	NULL
of	NULL
Uncoupling	NULL
Activation-Dependent	NULL
HS1	NULL
ifﬂéﬂf'lmmunolo	NULL
gy	NULL
Phosphorylation	NULL
from	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
Transcriptional	NULL
Activation	NULL
20	NULL
,	NULL
e	NULL
in	NULL
Jurkat	NULL
T	NULL
Cells	NULL
:	NULL
Differential	NULL
Signaling	NULL
T	NULL
?	NULL

ﬁ1nfggn§8	NULL
$	NULL
n	NULL
is	NULL
current	NULL
as	NULL
_	NULL
Through	NULL
CD3	NULL
and	NULL
the	NULL
Costimulatory	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Receptors	NULL
CD2	NULL
and	NULL
CD28	NULL
Jill	NULL
E.	NULL
Hutchcroft	NULL
,	NULL
Jacqueline	NULL
M.	NULL
Slavik	NULL
,	NULL
Huamao	NULL
Lin	NULL
,	NULL
Takeshi	NULL
Watanabe	NULL
and	NULL
Barbara	NULL
E.	NULL
Bierer	NULL
J	NULL
Immunol	NULL
1998	NULL
;	NULL
161:4506-4512	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/9/4506	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
57	NULL
articles	NULL
,	NULL
25	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/9/4506.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
Uncoupling	NULL
Activation-Dependent	NULL
HS1	NULL
Phosphorylation	NULL
from	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
Transcriptional	NULL
Activation	NULL
in	NULL
Jurkat	NULL
T	NULL
Cells	NULL
:	NULL
Differential	NULL
Signaling	NULL
Through	NULL
CD3	NULL
and	NULL
the	NULL
Costimulatory	NULL
Receptors	NULL
CD2	NULL
and	NULL
CD28	NULL
!	NULL

Jill	NULL
E.	NULL
Hutchcroft	NULL
,	NULL
``	NULL
*	NULL
Jacqueline	NULL
M.	NULL
Slavik	NULL
,	NULL
*	NULL
Huamao	NULL
Lin	NULL
,	NULL
*	NULL
Takeshi	NULL
Watanabe	NULL
,	NULL
``	NULL
and	NULL
Barbara	NULL
E.	NULL
Bierer®**	NULL
CD3	NULL
,	NULL
CD2	NULL
,	NULL
and	NULL
CD28	NULL
are	NULL
functionally	NULL
distinct	NULL
receptors	NULL
on	NULL
T	NULL
lymphocytes	NULL
.	NULL

Engagement	NULL
of	NULL
any	NULL
of	NULL
these	NULL
receptors	NULL
induces	NULL
the	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
shared	NULL
group	NULL
of	NULL
intracellular	NULL
signaling	NULL
proteins	NULL
,	NULL
including	NULL
Vav	NULL
,	NULL
Cbl	NULL
,	NULL
p85	NULL
phosphoinositide	NULL
3-kinase	NULL
,	NULL
and	NULL
the	NULL
Sre	NULL
family	NULL
kinases	NULL
Lok	NULL
and	NULL
Fyn	NULL
.	NULL

Ligation	NULL
of	NULL
CD3	NULL
also	NULL
induces	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
,	NULL
a	NULL
75-kDa	NULL
hematopoietic	NULL
cell-specific	NULL
intracellular	NULL
signaling	NULL
protein	NULL
of	NULL
unknown	NULL
function	NULL
.	NULL

We	NULL
have	NULL
examined	NULL
changes	NULL
in	NULL
HS1	NULL
phosphorylation	NULL
after	NULL
differential	NULL
stimulation	NULL
of	NULL
CD3	NULL
,	NULL
CD2	NULL
,	NULL
and	NULL
CD28	NULL
to	NULL
elucidate	NULL
its	NULL
role	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
to	NULL
further	NULL
delineate	NULL
the	NULL
signaling	NULL
pathways	NULL
recruited	NULL
by	NULL
these	NULL
receptors	NULL
.	NULL

Unlike	NULL
ligation	NULL
of	NULL
CD3	NULL
,	NULL
stimulation	NULL
with	NULL
anti-CD28	NULL
mAb	NULL
or	NULL
CHO	NULL
cells	NULL
expressing	NULL
the	NULL
CD28	NULL
ligands	NULL
CD80	NULL
or	NULL
CD86	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Additionally	NULL
,	NULL
no	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
was	NULL
induced	NULL
by	NULL
mitogenic	NULL
pairs	NULL
of	NULL
anti-CD2	NULL
mAbs	NULL
capable	NULL
of	NULL
activating	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
)	NULL
.	NULL

Costimulation	NULL
through	NULL
CD28	NULL
and/or	NULL
CD2	NULL
did	NULL
not	NULL
modulate	NULL
the	NULL
CD3-dependent	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
.	NULL

In	NULL
vivo	NULL
studies	NULL
indicated	NULL
that	NULL
CD3-induced	NULL
HS1	NULL
phosphorylation	NULL
was	NULL
dependent	NULL
upon	NULL
both	NULL
the	NULL
Src	NULL
family	NULL
tyrosine	NULL
kinase	NULL
Lek	NULL
and	NULL
the	NULL
tyrosine	NULL
phosphatase	NULL
CD45	NULL
,	NULL
did	NULL
not	NULL
require	NULL
MEK	NULL
]	NULL
1	NULL
kinase	NULL
activity	NULL
,	NULL
and	NULL
was	NULL
regulated	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
activation	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
CD3	NULL
,	NULL
CD28	NULL
,	NULL
and	NULL
CD2	NULL
activate	NULL
many	NULL
of	NULL
the	NULL
same	NULL
signaling	NULL
molecules	NULL
,	NULL
they	NULL
differed	NULL
in	NULL
their	NULL
capacity	NULL
to	NULL
induce	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
.	NULL

Furthermore	NULL
,	NULL
activation-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
was	NULL
not	NULL
required	NULL
for	NULL
NFAT	NULL
transcriptional	NULL
activation	NULL
.	NULL

-	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1998	NULL
,	NULL
161	NULL
:	NULL
4506-4512.	NULL
for	NULL
proliferation	NULL
and	NULL
differentiation	NULL
into	NULL
functionally	NULL
ac	NULL
tive	NULL
effector	NULL
T	NULL
cells	NULL
.	NULL

One	NULL
of	NULL
these	NULL
signals	NULL
can	NULL
be	NULL
provided	NULL
by	NULL
engagement	NULL
of	NULL
the	NULL
Ag-specific	NULL
TCR	NULL
(	NULL
TCR/CD3	NULL
)	NULL
complex	NULL
.	NULL

Engagement	NULL
of	NULL
the	NULL
TCR/CD3	NULL
complex	NULL
alone	NULL
,	NULL
without	NULL
a	NULL
second	NULL
costimulatory	NULL
signal	NULL
,	NULL
can	NULL
lead	NULL
to	NULL
T	NULL
cell	NULL
unresponsiveness	NULL
or	NULL
cell	NULL
death	NULL
by	NULL
apoptosis	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

Additional	NULL
intracellular	NULL
signals	NULL
are	NULL
triggered	NULL
when	NULL
the	NULL
costimulatory	NULL
receptors	NULL
CD28	NULL
and	NULL
CD2	NULL
bind	NULL
to	NULL
their	NULL
respective	NULL
ligands	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
APCs	NULL
.	NULL

Costimulation	NULL
through	NULL
CD28	NULL
or	NULL
CD2	NULL
dramatically	NULL
increases	NULL
the	NULL
production	NULL
of	NULL
several	NULL
lymphokines	NULL
,	NULL
including	NULL
IL-2	NULL
(	NULL
3-5	NULL
)	NULL
,	NULL
through	NULL
transcriptional	NULL
up-regulation	NULL
and	NULL
stabilization	NULL
of	NULL
cytokine	NULL
mRNA	NULL
and	NULL
can	NULL
regulate	NULL
the	NULL
induction	NULL
of	NULL
T	NULL
cell	NULL
anergy	NULL
(	NULL
6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
TCR	NULL
signaling	NULL
,	NULL
engagement	NULL
of	NULL
CD28	NULL
can	NULL
send	NULL
a	NULL
calcium-independent	NULL
signal	NULL
that	NULL
is	NULL
insensitive	NULL
to	NULL
the	NULL
immunosuppressive	NULL
drugs	NULL
cyclosporin	NULL
A	NULL
R	NULL
esting	NULL
T	NULL
lymphocytes	NULL
require	NULL
at	NULL
least	NULL
two	NULL
distinct	NULL
signals	NULL
*Department	NULL
of	NULL
Pediatric	NULL
Oncology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
;	NULL
*Department	NULL
of	NULL
Molecular	NULL
Immunology	NULL
,	NULL
Kyushu	NULL
University	NULL
,	NULL
Fukuoka	NULL
,	NULL
Japan	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Pediatrics	NULL
and	NULL
Medicine	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
Received	NULL
for	NULL
publication	NULL
March	NULL
24	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
June	NULL
23	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
research	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
Concern	NULL
Foundation	NULL
for	NULL
Cancer	NULL
Research/Cancer	NULL
Research	NULL
Institute	NULL
postdoctoral	NULL
fellowship	NULL
(	NULL
to	NULL
J.E.H	NULL
)	NULL
and	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
A135297	NULL
and	NULL
(	NULL
to	NULL
B.E.B	NULL
.	NULL
)	NULL

.	NULL

2	NULL
Current	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Purdue	NULL
University	NULL
,	NULL
West	NULL
Lafayette	NULL
,	NULL
IN	NULL
47907	NULL
.	NULL

3	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Barbara	NULL
E.	NULL
Bicrer	NULL
,	NULL
National	NULL
Heart	NULL
Lung	NULL
and	NULL
Blood	NULL
Institute	NULL
,	NULL
Building	NULL
10	NULL
,	NULL
Room	NULL
5D49	NULL
,	NULL
10	NULL
Center	NULL
Dr.	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
.	NULL

Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
and	NULL
FK506	NULL
,	NULL
inhibitors	NULL
of	NULL
the	NULL
intracellular	NULL
serine/threonine	NULL
phosphatase	NULL
calcineurin	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Engagement	NULL
of	NULL
either	NULL
CD3	NULL
,	NULL
CD28	NULL
,	NULL
or	NULL
CD2	NULL
can	NULL
trigger	NULL
shared	NULL
signaling	NULL
pathways	NULL
,	NULL
including	NULL
activation	NULL
of	NULL
phospholipase	NULL
Cy1	NULL
;	NULL
phosphoinositide	NULL
3-kinase	NULL
(	NULL
PI	NULL
3-kinase	NULL
)	NULL
*	NULL
;	NULL
Raf	NULL
;	NULL
and	NULL
the	NULL
cytoplasmic	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
Leck	NULL
,	NULL
Fyn	NULL
,	NULL
and	NULL
Itk	NULL
(	NULL
9-12	NULL
)	NULL
.	NULL

CD28	NULL
costimulation	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
enhance	NULL
T	NULL
cell	NULL
survival	NULL
following	NULL
TCR	NULL
stimulation	NULL
by	NULL
increasing	NULL
the	NULL
expression	NULL
of	NULL
Bel-x	NULL
,	NULL
(	NULL
13	NULL
)	NULL
and	NULL
by	NULL
inhibiting	NULL
the	NULL
induction	NULL
of	NULL
Fas	NULL
ligand	NULL
through	NULL
distinct	NULL
yet	NULL
undefined	NULL
pathways	NULL
(	NULL
14	NULL
)	NULL
.	NULL

HS1	NULL
is	NULL
a	NULL
75-kDa	NULL
intracellular	NULL
protein	NULL
of	NULL
uncharacterized	NULL
func-tion	NULL
,	NULL
expressed	NULL
only	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

It	NULL
was	NULL
originally	NULL
cloned	NULL
from	NULL
a	NULL
B	NULL
cell	NULL
cDNA	NULL
library	NULL
using	NULL
a	NULL
probe	NULL
to	NULL
the	NULL
adenovirus	NULL
2	NULL
transcription	NULL
factor	NULL
E1A	NULL
(	NULL
15	NULL
)	NULL
.	NULL

HS1	NULL
has	NULL
since	NULL
been	NULL
independently	NULL
isolated	NULL
on	NULL
three	NULL
separate	NULL
occasions	NULL
because	NULL
of	NULL
its	NULL
pronounced	NULL
tyrosine	NULL
phosphorylation	NULL
after	NULL
engagement	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
Ag	NULL
receptor	NULL
(	NULL
16	NULL
)	NULL
and	NULL
the	NULL
FeeRI	NULL
receptor	NULL
on	NULL
mast	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
and	NULL
because	NULL
of	NULL
its	NULL
binding	NULL
to	NULL
the	NULL
Sre	NULL
homology	NULL
3	NULL
(	NULL
SH3	NULL
)	NULL
domain	NULL
of	NULL
the	NULL
cytoplasmic	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
Lek	NULL
(	NULL
18	NULL
)	NULL
.	NULL

HS1	NULL
has	NULL
several	NULL
interesting	NULL
structural	NULL
features	NULL
that	NULL
suggest	NULL
that	NULL
it	NULL
may	NULL
be	NULL
an	NULL
important	NULL
immuno-regulatory	NULL
protein	NULL
.	NULL

The	NULL
amino-terminal	NULL
region	NULL
contains	NULL
three	NULL
copies	NULL
of	NULL
a	NULL
37	NULL
amino	NULL
acid-repeating	NULL
helix-turn-helix	NULL
motif	NULL
similar	NULL
to	NULL
that	NULL
found	NULL
in	NULL
many	NULL
DNA-binding	NULL
proteins	NULL
and	NULL
in	NULL
the	NULL
tyrosine	NULL
kinase	NULL
substrate	NULL
cortactin	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
carboxyl-terminal	NULL
region	NULL
contains	NULL
a	NULL
possible	NULL
nuclear	NULL
localization	NULL
signal	NULL
,	NULL
an	NULL
SH3	NULL
domain	NULL
,	NULL
a	NULL
proline-rich	NULL
region	NULL
,	NULL
and	NULL
two	NULL
acidic	NULL
a-helices	NULL
that	NULL
resemble	NULL
the	NULL
activating	NULL
region	NULL
of	NULL
prokaryotic	NULL
transcriptional	NULL
activator	NULL
proteins	NULL
.	NULL

*	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
PI	NULL
3-kinase	NULL
,	NULL
phosphoinositide	NULL
3-kinase	NULL
;	NULL
SH3	NULL
,	NULL
Src	NULL
homology	NULL
3	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
CHO	NULL
,	NULL
Chinese	NULL
hamster	NULL
ovary	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
PVDF	NULL
,	NULL
poly	NULL
(	NULL
vinylidene	NULL
difluoride	NULL
)	NULL
.	NULL

0022-1767/98/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
HS1	NULL
is	NULL
found	NULL
in	NULL
both	NULL
cytosolic	NULL
and	NULL
nuclear	NULL
cell	NULL
fractions	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Although	NULL
recent	NULL
studies	NULL
suggest	NULL
that	NULL
HS1	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
apoptotic	NULL
response	NULL
to	NULL
stimulation	NULL
of	NULL
the	NULL
Ag	NULL
receptor	NULL
on	NULL
B	NULL
and	NULL
immature	NULL
T	NULL
cells	NULL
(	NULL
20-23	NULL
)	NULL
,	NULL
the	NULL
function	NULL
and	NULL
regulation	NULL
of	NULL
HS1	NULL
in	NULL
lymphocytes	NULL
remain	NULL
to	NULL
be	NULL
established	NULL
.	NULL

We	NULL
investigated	NULL
activation-dependent	NULL
changes	NULL
in	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
a	NULL
diverse	NULL
set	NULL
of	NULL
stimulation	NULL
conditions	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
CD3	NULL
,	NULL
engagement	NULL
of	NULL
the	NULL
costimulatory	NULL
receptors	NULL
CD28	NULL
and	NULL
CD2	NULL
did	NULL
not	NULL
induce	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
.	NULL

We	NULL
found	NULL
that	NULL
T	NULL
cell	NULL
stimulation	NULL
conditions	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
mitogenic	NULL
pairs	NULL
of	NULL
anti-CD2	NULL
mAbs	NULL
)	NULL
that	NULL
were	NULL
capable	NULL
of	NULL
activating	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
did	NULL
not	NULL
induce	NULL
activation-dependent	NULL
HS1	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

The	NULL
in	NULL
vivo	NULL
regulation	NULL
of	NULL
HS1	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
CD3	NULL
was	NULL
then	NULL
examined	NULL
.	NULL

CD3-induced	NULL
HS1	NULL
phosphorylation	NULL
was	NULL
dependent	NULL
upon	NULL
both	NULL
the	NULL
Src	NULL
family	NULL
tyrosine	NULL
kinase	NULL
Lok	NULL
and	NULL
the	NULL
tyrosine	NULL
phosphatase	NULL
CD45	NULL
,	NULL
did	NULL
not	NULL
require	NULL
MEK	NULL
1	NULL
kinase	NULL
activity	NULL
,	NULL
and	NULL
was	NULL
regulated	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
activation	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
lines	NULL
and	NULL
cell	NULL
culture	NULL
The	NULL
T	NULL
cell	NULL
leukemia	NULL
cell	NULL
line	NULL
Jurkat	NULL
clone	NULL
J77	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
K.	NULL
Smith	NULL
(	NULL
Cornell	NULL
University	NULL
,	NULL
NY	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

The	NULL
Jurkat	NULL
subclones	NULL
J.Cam	NULL
!	NULL

1	NULL
(	NULL
deficient	NULL
in	NULL
Lok	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
)	NULL
and	NULL
145.01	NULL
(	NULL
deficient	NULL
in	NULL
the	NULL
tyrosine	NULL
phosphatase	NULL
CD45	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
ATCC	NULL
,	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
routinely	NULL
cultured	NULL
at	NULL
37°C	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
in	NULL
10	NULL
%	NULL
RPMI	NULL
1640	NULL
(	NULL
Mediatech	NULL
,	NULL
Herndon	NULL
,	NULL
VA	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
FCS	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
;	NULL
100	NULL
U/ml	NULL
penicillin	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
;	NULL
100	NULL
pg/ml	NULL
streptomycin	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
;	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.2	NULL
(	NULL
BioWhittaker	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
;	NULL
2	NULL
mM	NULL
glutamine	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
;	NULL
and	NULL
50	NULL
uM	NULL
2-ME	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Chinese	NULL
hamster	NULL
ovary	NULL
(	NULL
CHO	NULL
)	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
CD28	NULL
ligands	NULL
CD80	NULL
or	NULL
CD86	NULL
were	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
G.	NULL
Freeman	NULL
(	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
)	NULL
.	NULL

The	NULL
CHO	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
DME/F12	NULL
medium	NULL
(	NULL
Cell-gro	NULL
,	NULL
Fisher	NULL
,	NULL
Pittsburgh	NULL
,	NULL
PA	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
heat-inactivated	NULL
FCS	NULL
;	NULL
100	NULL
U/ml	NULL
penicillin	NULL
;	NULL
100	NULL
pg/ml	NULL
streptomycin	NULL
;	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.2	NULL
;	NULL
2	NULL
mM	NULL
glutamine	NULL
;	NULL
15	NULL
pg/ml	NULL
gentamicin	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
;	NULL
and	NULL
400	NULL
ug/ml	NULL
ge-neticin	NULL
(	NULL
G418	NULL
)	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
.	NULL

Antibodies	NULL
The	NULL
CD3	NULL
mAb	NULL
OKT3	NULL
(	NULL
ATCC	NULL
)	NULL
,	NULL
CDS	NULL
mAb	NULL
Leu	NULL
1	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
CD7	NULL
mAb	NULL
3A1	NULL
(	NULL
ATCC	NULL
)	NULL
,	NULL
CD28	NULL
mAb	NULL
9.3	NULL
(	NULL
Bristol	NULL
Myers	NULL
Squibb	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
,	NULL
CD43	NULL
mAb	NULL
L10	NULL
(	NULL
24	NULL
)	NULL
,	NULL
and	NULL
anti-phosphotyrosine	NULL
mAb	NULL
4G10	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
T.	NULL
Roberts	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
)	NULL
were	NULL
used	NULL
where	NULL
indicated	NULL
.	NULL

The	NULL
CD2	NULL
mAbs	NULL
T11	NULL
;	NULL
and	NULL
T11	NULL
;	NULL
(	NULL
kind-ly	NULL
provided	NULL
by	NULL
E.	NULL
L.	NULL
Reinherz	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
)	NULL
,	NULL
9-1	NULL
(	NULL
25	NULL
)	NULL
,	NULL
and	NULL
9.6	NULL
(	NULL
26	NULL
)	NULL
and	NULL
the	NULL
C1	NULL
polyclonal	NULL
Ab	NULL
against	NULL
the	NULL
Erk	NULL
kinases	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
J.	NULL
Blenis	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
were	NULL
also	NULL
used	NULL
.	NULL

The	NULL
HS1	NULL
polyclonal	NULL
antiserum	NULL
was	NULL
raised	NULL
against	NULL
a	NULL
human	NULL
HS1	NULL
peptide	NULL
(	NULL
Val	NULL
to	NULL
Ser	NULL
'	NULL
``	NULL
``	NULL
)	NULL
.	NULL

Polyclonal	NULL
antisera	NULL
against	NULL
the	NULL
85-kDa	NULL
subunit	NULL
of	NULL
PI	NULL
3-kinase	NULL
(	NULL
Up-state	NULL
Biotechnology	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
and	NULL
p95	NULL
Vav	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
were	NULL
used	NULL
in	NULL
immunoblotting	NULL
experiments	NULL
.	NULL

Preparation	NULL
of	NULL
cell	NULL
lysates	NULL
and	NULL
immunoprecipitates	NULL
Jurkat	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
resuspended	NULL
in	NULL
0.5	NULL
ml	NULL
buffer	NULL
A	NULL
(	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
100	NULL
U/ml	NULL
penicillin	NULL
;	NULL
100	NULL
pg/ml	NULL
streptomycin	NULL
;	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.2	NULL
;	NULL
and	NULL
2	NULL
mM	NULL
glutamine	NULL
)	NULL
and	NULL
incubated	NULL
with	NULL
1	NULL
ug/ml	NULL
mAb	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
and	NULL
then	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
1	NULL
X	NULL
10	NULL
``	NULL
CHO	NULL
cells	NULL
or	NULL
2	NULL
uM	NULL
pervanadate	NULL
or	NULL
pretreated	NULL
with	NULL
5	NULL
ng/ml	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
;	NULL
Sigma	NULL
)	NULL
or	NULL
10	NULL
uM	NULL
PD98059	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
a	NULL
selective	NULL
inhibitor	NULL
of	NULL
MEK1	NULL
activation	NULL
and	NULL
the	NULL
MAP	NULL
kinase	NULL
cascade	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
ice-cold	NULL
buffer	NULL
A	NULL
containing	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
(	NULL
Sig-ma	NULL
)	NULL
and	NULL
then	NULL
resuspended	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
;	NULL
150	NULL
mM	NULL
NaC	NULL
]	NULL
;	NULL
25	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.5	NULL
;	NULL
1	NULL
mM	NULL
EDTA	NULL
;	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
;	NULL
100	NULL
ug/tal	NULL
soybean	NULL
trypsin	NULL
inhibitor	NULL
;	NULL
10	NULL
pg/ml	NULL
leupeptin	NULL
;	NULL
and	NULL
10	NULL
pg/ml	NULL
apro-tinin	NULL
}	NULL
.	NULL

The	NULL
cell	NULL
lysates	NULL
(	NULL
corresponding	NULL
to	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cell	NULL
equivalents	NULL
for	NULL
each	NULL
immunoprecipitate	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
with	NULL
25	NULL
pl	NULL
agarose-conjugated	NULL
anti-phosphotyrosine	NULL
mAb	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
or	NULL
with	NULL
25	NULL
ul	NULL
protein	NULL
A-Sepharose	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
and	NULL
Abs	NULL
to	NULL
HS1	NULL
,	NULL
CD3	NULL
,	NULL
or	NULL
CD28	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
lysis	NULL
buffer	NULL
and	NULL
solubilized	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
,	NULL
and	NULL
the	NULL
4507	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
electrophoresis	NULL
on	NULL
6	NULL
to	NULL
15	NULL
%	NULL
SDS-polyacryl-amide	NULL
gradient	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
poly	NULL
(	NULL
vinylidene	NULL
difluoride	NULL
)	NULL
(	NULL
PVDF	NULL
)	NULL
membranes	NULL
(	NULL
Millipore	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Detergent	NULL
lysates	NULL
corresponding	NULL
to	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
included	NULL
in	NULL
immunoblotting	NULL
experiments	NULL
.	NULL

Western	NULL
blotting	NULL
analysis	NULL
The	NULL
PVDF	NULL
membranes	NULL
were	NULL
blocked	NULL
with	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
Tris-HCJ	NULL
,	NULL
pH	NULL
7.6	NULL
;	NULL
150	NULL
mM	NULL
NaCl	NULL
;	NULL
0.05	NULL
%	NULL
Tween-20	NULL
(	NULL
Sigma	NULL
)	NULL
;	NULL
and	NULL
1	NULL
%	NULL
BSA	NULL
(	NULL
Fraction	NULL
V	NULL
;	NULL
Sigma	NULL
)	NULL
and	NULL
then	NULL
incubated	NULL
sequentially	NULL
with	NULL
the	NULL
indicated	NULL
primary	NULL
Ab	NULL
followed	NULL
by	NULL
horseradish	NULL
peroxidase-coupled	NULL
secondary	NULL
Ab	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

The	NULL
Ab-labeled	NULL
protein	NULL
bands	NULL
were	NULL
detected	NULL
by	NULL
autoradiography	NULL
after	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
Amersham	NULL
)	NULL
development	NULL
.	NULL

NFAT	NULL
luciferase	NULL
assays	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
5	NULL
pg	NULL
of	NULL
an	NULL
NFAT	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
containing	NULL
a	NULL
minimal	NULL
IL-2	NULL
promoter	NULL
downstream	NULL
of	NULL
three	NULL
NFAT	NULL
binding	NULL
sites	NULL
(	NULL
27	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
then	NULL
pulsed	NULL
in	NULL
a	NULL
Life	NULL
Technologies	NULL
electroporator	NULL
at	NULL
250	NULL
V	NULL
and	NULL
800	NULL
F.	NULL
The	NULL
cells	NULL
remained	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
10	NULL
min	NULL
and	NULL
then	NULL
were	NULL
incubated	NULL
for	NULL
24	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
10	NULL
%	NULL
RPMI	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
6	NULL
h	NULL
with	NULL
the	NULL
indicated	NULL
mAbs	NULL
,	NULL
and	NULL
then	NULL
the	NULL
samples	NULL
were	NULL
prepared	NULL
using	NULL
the	NULL
Enhanced	NULL
Luciferase	NULL
Assay	NULL
Kit	NULL
(	NULL
Analytic	NULL
Luminescent	NULL
Laboratory	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

NFAT	NULL
reporter	NULL
activity	NULL
was	NULL
assessed	NULL
with	NULL
a	NULL
Monolight	NULL
2010	NULL
luminometer	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
is	NULL
presented	NULL
as	NULL
the	NULL
fold	NULL
activation	NULL
relative	NULL
to	NULL
the	NULL
basal	NULL
level	NULL
detected	NULL
in	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
reporter	NULL
plasmid	NULL
.	NULL

Results	NULL
Engagement	NULL
of	NULL
CD3	NULL
but	NULL
not	NULL
of	NULL
the	NULL
costimulatory	NULL
receptors	NULL
CD28	NULL
or	NULL
CD2	NULL
induced	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HSI	NULL
HS1	NULL
,	NULL
a	NULL
hematopoietic	NULL
cell-specific	NULL
signaling	NULL
protein	NULL
,	NULL
is	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
residues	NULL
in	NULL
response	NULL
to	NULL
ligation	NULL
of	NULL
Ag	NULL
receptors	NULL
on	NULL
B	NULL
cells	NULL
(	NULL
16	NULL
,	NULL
28	NULL
)	NULL
,	NULL
T	NULL
cells	NULL
(	NULL
21	NULL
)	NULL
,	NULL
and	NULL
mast	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
.	NULL

We	NULL
examined	NULL
whether	NULL
engagement	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
costimulatory	NULL
receptor	NULL
CD28	NULL
,	NULL
CD2	NULL
,	NULL
or	NULL
other	NULL
T	NULL
cell	NULL
surface	NULL
receptors	NULL
could	NULL
induce	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Anti-phosphotyrosine	NULL
imnmunoprecipitates	NULL
were	NULL
prepared	NULL
from	NULL
Nonidet	NULL
P-40	NULL
detergent	NULL
lysates	NULL
of	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
stimulated	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37°C	NULL
with	NULL
mAbs	NULL
to	NULL
different	NULL
T	NULL
lymphocyte	NULL
transmembrane	NULL
receptor	NULL
molecules	NULL
or	NULL
that	NULL
had	NULL
been	NULL
chemically	NULL
activated	NULL
with	NULL
pervanadate	NULL
.	NULL

The	NULL
imnmunoprecipitated	NULL
phosphoproteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
PVDF	NULL
membranes	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
an	NULL
HS1	NULL
polyclonal	NULL
antiserum	NULL
raised	NULL
against	NULL
a	NULL
human	NULL
HS1	NULL
peptide	NULL
(	NULL
Val	NULL
``	NULL
``	NULL
®	NULL
to	NULL
Ser	NULL
``	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
stimulation	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
anti-CD3	NULL
mAb	NULL
led	NULL
to	NULL
the	NULL
immunoprecipitation	NULL
of	NULL
a	NULL
tyrosine-phosphorylated	NULL
75-kDa	NULL
protein	NULL
that	NULL
was	NULL
specifically	NULL
detected	NULL
by	NULL
anti-HS1	NULL
antisera	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

This	NULL
phosphoprotein	NULL
comigrated	NULL
with	NULL
the	NULL
75-kDa	NULL
cell	NULL
lysate	NULL
protein	NULL
detected	NULL
by	NULL
anti-HS1	NULL
antisera	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
was	NULL
not	NULL
found	NULL
in	NULL
anti-phosphotyrosine	NULL
immunoprecipitates	NULL
prepared	NULL
from	NULL
unstimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
CD3-dependent	NULL
induction	NULL
of	NULL
HS1	NULL
phosphorylation	NULL
was	NULL
detectable	NULL
within	NULL
45	NULL
s	NULL
of	NULL
stimulation	NULL
,	NULL
maximal	NULL
at	NULL
7	NULL
min	NULL
,	NULL
and	NULL
notably	NULL
decreased	NULL
by	NULL
30	NULL
min	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
stimulation	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
anti-CD3	NULL
mAb	NULL
was	NULL
sufficient	NULL
to	NULL
induce	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
,	NULL
consistent	NULL
with	NULL
published	NULL
studies	NULL
in	NULL
murine	NULL
systems	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
2	NULL
uM	NULL
pervanadate	NULL
,	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
tyrosine	NULL
phosphatase	NULL
activity	NULL
,	NULL
also	NULL
induced	NULL
robust	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
on	NULL
tyrosine	NULL
residues	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
neither	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
anti-CD28	NULL
nor	NULL
with	NULL
anti-CD2	NULL
mAbs	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
led	NULL
to	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Tyrosine-phosphorylated	NULL
HS1	NULL
was	NULL
also	NULL
not	NULL
detected	NULL
in	NULL
Jurkat	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
stimulated	NULL
with	NULL
mAbs	NULL
to	NULL
CD5	NULL
,	NULL
CD7	NULL
,	NULL
or	NULL
CD43	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
5	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Because	NULL
stimulation	NULL
of	NULL
CD28	NULL
with	NULL
its	NULL
physiologic	NULL
ligands	NULL
CD80	NULL
and	NULL
CD86	NULL
can	NULL
recruit	NULL
different	NULL
intracellular	NULL
signals	NULL
from	NULL
anti-CD28	NULL
mAb	NULL
(	NULL
Ref	NULL
.	NULL

29	NULL
and	NULL
our	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
stimulating	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
these	NULL
ligands	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4508	NULL
A	NULL
as	NULL
&	NULL
&	NULL
rt	NULL
@	NULL
Fin	NULL
a	NULL
$	NULL
0	NULL
Q6	NULL
live	NULL
Q9	NULL
Gk	NULL
‘	NULL
bg	NULL
Y	NULL
o*	NULL
x	NULL
g	NULL
«	NULL
P	NULL
GG	NULL
<	NULL
b	NULL
Stimulation	NULL
:	NULL
Y	NULL
'	NULL
-	NULL
*	NULL
&	NULL
£	NULL
~97	NULL
HS-1	NULL
-	NULL
»	NULL
__	NULL
«	NULL
®	NULL
»	NULL
i	NULL
.	NULL

-66	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
B	NULL
+	NULL
Jurkat	NULL
cells	NULL
os	NULL
$	NULL
$	NULL
-	NULL
JI	NULL
060630	NULL
0	NULL
&	NULL
2	NULL
}	NULL
?	NULL

g	NULL
»	NULL
“	NULL
gt-	NULL
<	NULL
5	NULL
”	NULL
V	NULL
Q	NULL
Stimulation	NULL
:	NULL
&	NULL
&	NULL
&	NULL
FF	NULL
&	NULL
-	NULL
¢	NULL
§	NULL
$	NULL
HS-1	NULL
-	NULL
»	NULL
**	NULL
)	NULL
ls6	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
FIGURE	NULL
1	NULL
.	NULL

CD3-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
.	NULL

Anti	NULL
phosphotyrosine	NULL
immunoprecipitates	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10	NULL
``	NULL
)	NULL
.	NULL

A	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
that	NULL
were	NULL
untreated	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
1	NULL
pg/ml	NULL
anti-CD2	NULL
mAbs	NULL
Tl1	NULL
,	NULL
+	NULL
Tl1	NULL
;	NULL
,	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
9	NULL
)	NULL
,	NULL
the	NULL
anti-CD3	NULL
mAb	NULL
OKT3	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
the	NULL
anti-CD5	NULL
mAb	NULL
Leu	NULL
1	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
the	NULL
anti-CD7	NULL
mAb	NULL
3A1	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
the	NULL
anti-CD28	NULL
mAb	NULL
9.3	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
9	NULL
)	NULL
,	NULL
the	NULL
anti-CD43	NULL
mAb	NULL
L10	NULL
(	NULL
Zane	NULL
8	NULL
)	NULL
,	NULL
or	NULL
2	NULL
uM	NULL
pervanadate	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
that	NULL
were	NULL
untreated	NULL
(	NULL
Zane	NULL
7	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
mock-transfected	NULL
CHO	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10	NULL
``	NULL
)	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
,	NULL
CHO-CD80	NULL
cells	NULL
(	NULL
Lane	NULL
5	NULL
)	NULL
,	NULL
CHO-CD86	NULL
cells	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
1	NULL
ug/ml	NULL
anti-CD28	NULL
mAb	NULL
9.3	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
1	NULL
ug/ml	NULL
!	NULL

anti-CD28	NULL
mAb	NULL
9.3	NULL
,	NULL
and	NULL
5	NULL
ug/ml	NULL
goat	NULL
anti-mouse	NULL
secondary	NULL
cross-linking	NULL
Ab	NULL
(	NULL
Zane	NULL
9	NULL
)	NULL
or	NULL
1	NULL
pg/ml	NULL
anti-CD3	NULL
mAb	NULL
OKT3	NULL
(	NULL
Zane	NULL
10	NULL
)	NULL
.	NULL

Anti-phosphotyrosine	NULL
immunoprecipitates	NULL
were	NULL
also	NULL
prepared	NULL
from	NULL
the	NULL
mock-transfected	NULL
CHO	NULL
cells	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
,	NULL
CHO-CD80	NULL
cells	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
and	NULL
CHO-CD86	NULL
cells	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
alone	NULL
.	NULL

All	NULL
stimulations	NULL
were	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
on	NULL
6	NULL
to	NULL
15	NULL
%	NULL
SDS-PAGE	NULL
gradient	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
PVDF	NULL
membranes	NULL
,	NULL
probed	NULL
with	NULL
anti-HS1	NULL
an-tisera	NULL
,	NULL
and	NULL
detected	NULL
by	NULL
autoradiography	NULL
after	NULL
enhanced	NULL
chemiluminescence	NULL
treatment	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
migration	NULL
patterns	NULL
of	NULL
HS1	NULL
and	NULL
molecular	NULL
mass	NULL
markers	NULL
are	NULL
indicated	NULL
.	NULL

No	NULL
enhancement	NULL
of	NULL
HS1	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
observed	NULL
in	NULL
Jurkat	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
stimulated	NULL
with	NULL
CD80-	NULL
or	NULL
CD86-trans-fected	NULL
CHO	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
4-6	NULL
)	NULL
over	NULL
the	NULL
background	NULL
levels	NULL
detected	NULL
in	NULL
unstimulated	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
or	NULL
in	NULL
mock-CHO-stim-ulated	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
Jurkat	NULL
cells	NULL
.	NULL

These	NULL
stimulation	NULL
conditions	NULL
were	NULL
sufficient	NULL
to	NULL
induce	NULL
the	NULL
physical	NULL
association	NULL
of	NULL
p85	NULL
PI	NULL
3-kinase	NULL
with	NULL
CD28	NULL
(	NULL
Ref	NULL
.	NULL

10	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Anti-HS1	NULL
antisera	NULL
did	NULL
not	NULL
detect	NULL
any	NULL
75-kDa	NULL
proteins	NULL
in	NULL
anti-phosphotyrosine	NULL
immunoprecipitates	NULL
prepared	NULL
from	NULL
detergent	NULL
lysates	NULL
of	NULL
the	NULL
different	NULL
CHO	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
1-3	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
lack	NULL
of	NULL
expression	NULL
of	NULL
HS1	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Stimulation	NULL
of	NULL
the	NULL
Jurkat	NULL
cells	NULL
with	NULL
anti-CD28	NULL
mAb	NULL
that	NULL
was	NULL
further	NULL
cross-linked	NULL
with	NULL
secondary	NULL
Ab	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
failed	NULL
to	NULL
induce	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
signaling	NULL
pathways	NULL
triggered	NULL
by	NULL
engagement	NULL
of	NULL
the	NULL
CD3	NULL
and	NULL
either	NULL
the	NULL
CD28	NULL
or	NULL
CD2	NULL
receptors	NULL
on	NULL
Jurkat	NULL
cells	NULL
can	NULL
be	NULL
distinguished	NULL
by	NULL
their	NULL
differing	NULL
capacity	NULL
to	NULL
induce	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HSI	NULL
.	NULL

We	NULL
confirmed	NULL
that	NULL
our	NULL
stimulation	NULL
conditions	NULL
with	NULL
anti-CD28	NULL
and	NULL
anti-CD2	NULL
mAbs	NULL
were	NULL
sufficient	NULL
to	NULL
induce	NULL
activation-dependent	NULL
changes	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
other	NULL
intracellular	NULL
signaling	NULL
proteins	NULL
.	NULL

Ligation	NULL
with	NULL
anti-CD28	NULL
mAb	NULL
led	NULL
to	NULL
the	NULL
association	NULL
of	NULL
CD28	NULL
with	NULL
the	NULL
85-kDa	NULL
regulatory	NULL
subunit	NULL
of	NULL
PI	NULL
3-kinase	NULL
(	NULL
Ref	NULL
.	NULL

30	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p95	NULL
Vav	NULL
(	NULL
see	NULL
below	NULL
)	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
the	NULL
CD2	NULL
receptor	NULL
induced	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
multiple	NULL
other	NULL
intracellular	NULL
proteins	NULL
HS1	NULL
AND	NULL
T	NULL
CELL	NULL
SIGNALING	NULL
Y	NULL
5	NULL
8	NULL
§	NULL
Stimulation	NULL
:	NULL
&	NULL
&	NULL
-206	NULL
V	NULL
Q	NULL
-125	NULL
6	NULL
j	NULL
-	NULL
:	NULL
!	NULL

-	NULL
88	NULL
Stimulation	NULL
:	NULL
-_	NULL
&	NULL
-	NULL
>	NULL
-	NULL
p85	NULL
_	NULL
,	NULL
.	NULL

__	NULL
~	NULL
88	NULL
-	NULL
>	NULL
._	NULL
am	NULL
SB	NULL
Pis	NULL
K	NULL
-	NULL
>	NULL
s	NULL
tlk	NULL
mam	NULL
.	NULL

4g	NULL
1	NULL
2	NULL
3	NULL
,	NULL
Lysate	NULL
-	NULL
uPY	NULL
IP	NULL
's	NULL
-	NULL
|__	NULL
uk	NULL
p85	NULL
PI3	NULL
K	NULL
blot	NULL
-	NULL
35	NULL
-	NULL
»	NULL
«	NULL
»	NULL
-	NULL
21	NULL
1	NULL
2	NULL
3	NULL
uPY	NULL
IP	NULL
's	NULL
PY	NULL
blot	NULL
FIGURE	NULL
2	NULL
.	NULL

-	NULL
Induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
mitogenic	NULL
pairs	NULL
of	NULL
anti-CD2	NULL
mAbs	NULL
.	NULL

Left	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
untreated	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
1	NULL
pg/ml	NULL
of	NULL
the	NULL
anti-CD2	NULL
mAbs	NULL
T11	NULL
,	NULL
;	NULL
,	NULL
and	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
or	NULL
1	NULL
ug/tal	NULL
anti-CD3	NULL
mAb	NULL
OKT3	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Tyrosine-phosphorylated	NULL
proteins	NULL
were	NULL
detected	NULL
by	NULL
immunoprecipitation	NULL
and	NULL
blotting	NULL
with	NULL
anti-phosphotyrosine	NULL
mAb	NULL
.	NULL

The	NULL
migration	NULL
patterns	NULL
of	NULL
several	NULL
induc-ibly	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
(	NULL
arrows	NULL
)	NULL
and	NULL
molecular	NULL
mass	NULL
markers	NULL
are	NULL
indicated	NULL
.	NULL

Right	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
untreated	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
1	NULL
pg/ml	NULL
of	NULL
the	NULL
anti-CD2	NULL
mAbs	NULL
T11	NULL
;	NULL
,	NULL
and	NULL
Tl1	NULL
,	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Proteins	NULL
in	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
cell	NULL
lysates	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
anti-phosphotyrosine	NULL
immunoprecipitates	NULL
(	NULL
Zanes	NULL
2-3	NULL
)	NULL
were	NULL
immunoblotted	NULL
with	NULL
anti-p85	NULL
PI	NULL
3	NULL
kinase	NULL
antisera	NULL
.	NULL

The	NULL
migration	NULL
patterns	NULL
of	NULL
p85	NULL
PI	NULL
3	NULL
kinase	NULL
and	NULL
molecular	NULL
mass	NULL
markers	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
leff	NULL
)	NULL
,	NULL
including	NULL
the	NULL
specific	NULL
phosphorylation	NULL
of	NULL
p85	NULL
PI	NULL
3-kinase	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
right	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
illustrate	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
responses	NULL
triggered	NULL
through	NULL
the	NULL
different	NULL
cell	NULL
surface	NULL
receptors	NULL
.	NULL

Activation-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HSI	NULL
is	NULL
not	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
NFAT	NULL
activity	NULL
Inducible	NULL
gene	NULL
expression	NULL
is	NULL
a	NULL
crucial	NULL
effector	NULL
function	NULL
of	NULL
specific	NULL
T	NULL
cell	NULL
signaling	NULL
cascades	NULL
.	NULL

Antigenic	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
induces	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
NFAT	NULL
family	NULL
members	NULL
that	NULL
are	NULL
required	NULL
for	NULL
the	NULL
production	NULL
of	NULL
IL-2	NULL
(	NULL
31	NULL
)	NULL
.	NULL

We	NULL
investigated	NULL
whether	NULL
HS1	NULL
was	NULL
a	NULL
component	NULL
of	NULL
the	NULL
signaling	NULL
cascades	NULL
leading	NULL
to	NULL
NFAT	NULL
activation	NULL
and	NULL
IL-2	NULL
production	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
tran-siently	NULL
transfected	NULL
with	NULL
an	NULL
NFAT	NULL
luciferase	NULL
reporter	NULL
construct	NULL
containing	NULL
a	NULL
minimal	NULL
IL-2	NULL
promoter	NULL
downstream	NULL
of	NULL
three	NULL
NFAT	NULL
binding	NULL
sites	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
the	NULL
anti-CD3	NULL
mAb	NULL
OKT3	NULL
,	NULL
the	NULL
anti-CD2	NULL
mAbs	NULL
T11	NULL
,	NULL
;	NULL
,	NULL
and	NULL
T11	NULL
;	NULL
,	NULL
or	NULL
the	NULL
anti-CD28	NULL
mAb	NULL
9.3	NULL
for	NULL
6	NULL
h	NULL
before	NULL
harvest	NULL
and	NULL
quantification	NULL
of	NULL
luciferase	NULL
activity	NULL
.	NULL

Stimulation	NULL
with	NULL
mitogenic	NULL
pairs	NULL
of	NULL
CD2	NULL
mAbs	NULL
was	NULL
sufficient	NULL
to	NULL
induce	NULL
NFAT	NULL
luciferase	NULL
expression	NULL
;	NULL
this	NULL
response	NULL
was	NULL
significantly	NULL
greater	NULL
(	NULL
3.5-fold	NULL
)	NULL
than	NULL
that	NULL
to	NULL
stimulation	NULL
of	NULL
CD3	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

CD28	NULL
costimulation	NULL
enhanced	NULL
both	NULL
the	NULL
CD3-	NULL
and	NULL
the	NULL
CD2-dependent	NULL
induction	NULL
of	NULL
NFAT	NULL
luciferase	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
the	NULL
response	NULL
to	NULL
combined	NULL
stimulation	NULL
through	NULL
CD3	NULL
and	NULL
CD2	NULL
was	NULL
no	NULL
greater	NULL
than	NULL
that	NULL
seen	NULL
to	NULL
CD2	NULL
alone	NULL
.	NULL

In	NULL
marked	NULL
contrast	NULL
to	NULL
the	NULL
NFAT	NULL
assays	NULL
,	NULL
stimulation	NULL
with	NULL
either	NULL
of	NULL
two	NULL
different	NULL
mitogenic	NULL
pairs	NULL
of	NULL
CD2	NULL
mAbs	NULL
,	NULL
T11	NULL
,	NULL
;	NULL
,	NULL
plus	NULL
T11	NULL
,	NULL
or	NULL
9-1	NULL
plus	NULL
9.6	NULL
,	NULL
did	NULL
not	NULL
increase	NULL
the	NULL
amount	NULL
of	NULL
tyrosine-phosphorylated	NULL
HS1	NULL
over	NULL
the	NULL
background	NULL
levels	NULL
present	NULL
in	NULL
unstimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Combined	NULL
stimulation	NULL
with	NULL
anti-CD2	NULL
and	NULL
anti-CD28	NULL
mAbs	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
2	NULL
,	NULL
8	NULL
,	NULL
and	NULL
10	NULL
)	NULL
failed	NULL
to	NULL
induce	NULL
the	NULL
tyrosine-phosphorylated	NULL
HS1	NULL
,	NULL
despite	NULL
their	NULL
ability	NULL
to	NULL
induce	NULL
robust	NULL
NFAT	NULL
transcriptional	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
HS1	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
with	NULL
mitogenic	NULL
pairs	NULL
of	NULL
anti-CD2	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
aa	NULL
P	NULL
o	NULL
o	NULL
C	NULL
NFAT	NULL
Luciferase	NULL
Activity	NULL
&	NULL
®	NULL
0	NULL
o	NULL
ho	NULL
o	NULL
g	NULL
|-	NULL
;	NULL
;	NULL
3	NULL
none	NULL
CD3	NULL
CD2	NULL
CD28	NULL
CD3	NULL
CD3	NULL
CD2	NULL
+CD2	NULL
+CD28	NULL
-	NULL
+CD28	NULL
mAb	NULL
Stimulation	NULL
B	NULL
~	NULL
'D	NULL
S8	NULL
.	NULL

L	NULL
p	NULL
#	NULL
@	NULL
*	NULL
x	NULL
-	NULL
o	NULL
3:31	NULL
mX	NULL
wy	NULL
*	NULL
A	NULL
3	NULL
m	NULL
x	NULL
x	NULL
P	NULL
g	NULL
R23	NULL
Lz	NULL
PS	NULL
b	NULL
V	NULL
¥	NULL
¥	NULL
4	NULL
¥	NULL
L	NULL
¥	NULL
.	NULL

a	NULL
J	NULL
&	NULL
G	NULL
Q	NULL
Q	NULL
Q	NULL
G	NULL
Q	NULL
I	NULL
Q	NULL
Stimulation	NULL
:	NULL
_	NULL
_X	NULL
*	NULL
é	NULL
)	NULL
ac	NULL
»	NULL
)	NULL
0C	NULL
)	NULL
G0	NULL
a	NULL
?	NULL

é	NULL
’	NULL
Q	NULL
g	NULL
?	NULL
)	NULL

HS-1	NULL
-	NULL
>	NULL
-	NULL
«	NULL
sm	NULL
»	NULL
l	NULL
we	NULL
:	NULL
--	NULL
«	NULL
uke	NULL
-66	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
FIGURE	NULL
3	NULL
.	NULL

Differential	NULL
activation	NULL
of	NULL
NFAT	NULL
reporter	NULL
expression	NULL
and	NULL
HS1	NULL
tyrosine	NULL
phosphorylation	NULL
following	NULL
engagement	NULL
of	NULL
CD3	NULL
,	NULL
CD2	NULL
,	NULL
or	NULL
CD28	NULL
.	NULL

A	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
NFAT	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
stimulated	NULL
as	NULL
indicated	NULL
with	NULL
anti-CD3	NULL
mAb	NULL
OKT3	NULL
,	NULL
anti-CD2	NULL
mAbs	NULL
T11	NULL
;	NULL
and	NULL
T11s	NULL
,	NULL
or	NULL
anti-CD28	NULL
mAb	NULL
9.3	NULL
for	NULL
an	NULL
additional	NULL
6	NULL
h	NULL
before	NULL
harvest	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
mea-sured	NULL
,	NULL
and	NULL
the	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
fold	NULL
induction	NULL
relative	NULL
to	NULL
un-stimulated	NULL
,	NULL
vector-transfected	NULL
cells	NULL
(	NULL
assigned	NULL
an	NULL
arbitrary	NULL
value	NULL
of	NULL
1	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
a	NULL
single	NULL
experiment	NULL
are	NULL
shown	NULL
that	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

B	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
1	NULL
pg/ml	NULL
anti-CD3	NULL
mAb	NULL
OKT3	NULL
(	NULL
Zanes	NULL
3	NULL
,	NULL
7	NULL
,	NULL
and	NULL
9	NULL
)	NULL
,	NULL
anti-CD28	NULL
mAb	NULL
9.3	NULL
(	NULL
Zanes	NULL
4	NULL
,	NULL
8	NULL
,	NULL
and	NULL
10	NULL
)	NULL
,	NULL
anti-CD2	NULL
mAbs	NULL
T11	NULL
;	NULL
,	NULL
and	NULL
T11	NULL
;	NULL
(	NULL
lanes	NULL
5	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
)	NULL
,	NULL
or	NULL
anti-CD2	NULL
mAbs	NULL
9.1	NULL
and	NULL
9-6	NULL
(	NULL
Zanes	NULL
6	NULL
,	NULL
9	NULL
,	NULL
and	NULL
10	NULL
)	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Proteins	NULL
in	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
cell	NULL
lysates	NULL
(	NULL
Zane	NULL
Z	NULL
)	NULL
or	NULL
anti-phosphotyrosine	NULL
immunoprecipitates	NULL
(	NULL
lanes	NULL
2-/0	NULL
)	NULL
were	NULL
immunoblotted	NULL
with	NULL
anti-HS1	NULL
antisera	NULL
.	NULL

The	NULL
migration	NULL
patterns	NULL
of	NULL
HS1	NULL
and	NULL
molecular	NULL
mass	NULL
markers	NULL
are	NULL
indicated	NULL
.	NULL

mAbs	NULL
was	NULL
particularly	NULL
surprising	NULL
,	NULL
because	NULL
CD2-dependent	NULL
signaling	NULL
pathways	NULL
are	NULL
often	NULL
considered	NULL
to	NULL
be	NULL
qualitatively	NULL
similar	NULL
to	NULL
CD3-dependent	NULL
pathways	NULL
and	NULL
,	NULL
as	NULL
we	NULL
and	NULL
others	NULL
have	NULL
shown	NULL
,	NULL
are	NULL
sufficient	NULL
to	NULL
induce	NULL
IL-2	NULL
production	NULL
(	NULL
32-35	NULL
)	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
distinguish	NULL
the	NULL
conditions	NULL
required	NULL
for	NULL
HS1	NULL
tyrosine	NULL
phosphorylation	NULL
from	NULL
those	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
NFAT	NULL
,	NULL
suggesting	NULL
that	NULL
HS1	NULL
is	NULL
not	NULL
a	NULL
necessary	NULL
component	NULL
of	NULL
the	NULL
signaling	NULL
pathway	NULL
leading	NULL
to	NULL
IL-2	NULL
production	NULL
.	NULL

Neither	NULL
of	NULL
the	NULL
costimulatory	NULL
receptors	NULL
CD28	NULL
or	NULL
CD2	NULL
modulate	NULL
the	NULL
CD3-dependent	NULL
phosphorylation	NULL
of	NULL
HSI	NULL
The	NULL
costimulatory	NULL
signals	NULL
provided	NULL
by	NULL
CD28	NULL
and	NULL
CD2	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
fully	NULL
characterized	NULL
.	NULL

We	NULL
examined	NULL
whether	NULL
engagement	NULL
of	NULL
these	NULL
receptors	NULL
could	NULL
potentiate	NULL
or	NULL
inhibit	NULL
a	NULL
suboptimal	NULL
signal	NULL
through	NULL
CD3	NULL
.	NULL

Incubation	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
10	NULL
ng/m	NULL
!	NULL

anti-CD3	NULL
mAb	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
any	NULL
detectable	NULL
increases	NULL
in	NULL
HS1	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

This	NULL
basal	NULL
level	NULL
of	NULL
HS1	NULL
phosphorylation	NULL
was	NULL
not	NULL
augmented	NULL
by	NULL
costimulation	NULL
through	NULL
CD28	NULL
or	NULL
CD2	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
costimulation	NULL
with	NULL
either	NULL
anti-CD2	NULL
or	NULL
anti-CD28	NULL
mAbs	NULL
did	NULL
not	NULL
change	NULL
the	NULL
level	NULL
of	NULL
tyrosine	NULL
4509	NULL
a	NULL
&	NULL
€	NULL
8	NULL
$	NULL
S	NULL
)	NULL
m	NULL
é	NULL
?	NULL

a	NULL
?	NULL

”	NULL
a	NULL
0	NULL
;	NULL
—	NULL
<	NULL
G	NULL
€	NULL
A	NULL
&	NULL
$	NULL
$	NULL
$	NULL
o	NULL
m-	NULL
®	NULL
mG	NULL
&	NULL
5	NULL
&	NULL
a	NULL
8	NULL
385	NULL
a	NULL
$	NULL
|	NULL
_	NULL
Bj	NULL
a	NULL
a	NULL
a	NULL
o	NULL
Stimulation	NULL
:	NULL
$	NULL
-	NULL
--	NULL
F	NULL
F	NULL
F	NULL
F	NULL
Y	NULL
F	NULL
§	NULL
¥	NULL
HS-1	NULL
-	NULL
»	NULL
_-	NULL
-66	NULL
1	NULL
2	NULL
3	NULL
40	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
FIGURE	NULL
4	NULL
.	NULL

Effect	NULL
of	NULL
CD28	NULL
or	NULL
CD2	NULL
engagement	NULL
on	NULL
suboptimal	NULL
CD3	NULL
stimulation	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
Zanes	NULL
I	NULL
and	NULL
2	NULL
)	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
10	NULL
ng/ml	NULL
anti-CD3	NULL
mAb	NULL
OKT3	NULL
(	NULL
Zanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
7	NULL
)	NULL
,	NULL
1	NULL
pg/ml	NULL
anti-CD3	NULL
mAb	NULL
OKT3	NULL
(	NULL
Zanes	NULL
8-10	NULL
)	NULL
,	NULL
anti-CD2	NULL
mAbs	NULL
T11	NULL
,	NULL
;	NULL
and	NULL
Tl	NULL
;	NULL
(	NULL
anes	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
9	NULL
)	NULL
,	NULL
or	NULL
anti-CD28	NULL
mAb	NULL
9.3	NULL
(	NULL
Zanes	NULL
5	NULL
,	NULL
7	NULL
,	NULL
and	NULL
10	NULL
)	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Proteins	NULL
in	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
cell	NULL
lysates	NULL
(	NULL
Zane	NULL
7	NULL
)	NULL
or	NULL
anti-phosphotyrosine	NULL
immunoprecipitates	NULL
(	NULL
lanes	NULL
2-10	NULL
)	NULL
were	NULL
immunoblotted	NULL
with	NULL
anti-HS1	NULL
antisera	NULL
.	NULL

The	NULL
migration	NULL
patterns	NULL
of	NULL
HS1	NULL
and	NULL
molecular	NULL
mass	NULL
markers	NULL
are	NULL
indicated	NULL
.	NULL

phosphorylated	NULL
HS1	NULL
from	NULL
that	NULL
seen	NULL
after	NULL
stimulation	NULL
with	NULL
optimal	NULL
concentrations	NULL
of	NULL
anti-CD3	NULL
mAb	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
8-10	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
HS1	NULL
tyrosine	NULL
phosphorylation	NULL
is	NULL
exquisitely	NULL
dependent	NULL
upon	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
activating	NULL
signal	NULL
,	NULL
occurring	NULL
in	NULL
response	NULL
to	NULL
engagement	NULL
of	NULL
CD3	NULL
but	NULL
not	NULL
CD28	NULL
,	NULL
CD2	NULL
,	NULL
CD5	NULL
,	NULL
CD7	NULL
,	NULL
or	NULL
CD43	NULL
.	NULL

Ag	NULL
receptor	NULL
specificity	NULL
has	NULL
also	NULL
been	NULL
seen	NULL
following	NULL
engagement	NULL
of	NULL
the	NULL
Ag	NULL
receptors	NULL
on	NULL
B	NULL
cells	NULL
(	NULL
16	NULL
,	NULL
17	NULL
,	NULL
28	NULL
)	NULL
and	NULL
FeeRI	NULL
on	NULL
mast	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
the	NULL
costimulatory	NULL
signal	NULL
triggered	NULL
by	NULL
engagement	NULL
of	NULL
CD28	NULL
and	NULL
CD2	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
influence	NULL
the	NULL
level	NULL
of	NULL
HS1	NULL
phosphorylation	NULL
.	NULL

Lock	NULL
and	NULL
CD45	NULL
are	NULL
required	NULL
for	NULL
CD3-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HSI	NULL
in	NULL
vivo	NULL
Studies	NULL
in	NULL
mice	NULL
rendered	NULL
genetically	NULL
deficient	NULL
in	NULL
the	NULL
Src	NULL
family	NULL
tyrosine	NULL
kinase	NULL
Lyn	NULL
have	NULL
shown	NULL
that	NULL
this	NULL
kinase	NULL
is	NULL
required	NULL
for	NULL
activation-dependent	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
on	NULL
tyrosine	NULL
in	NULL
response	NULL
to	NULL
engagement	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
Ag	NULL
receptor	NULL
(	NULL
22	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
studies	NULL
have	NULL
also	NULL
shown	NULL
that	NULL
the	NULL
SH3	NULL
domain	NULL
of	NULL
the	NULL
Src	NULL
family	NULL
tyrosine	NULL
kinase	NULL
Lock	NULL
can	NULL
bind	NULL
HS1	NULL
;	NULL
however	NULL
,	NULL
this	NULL
binding	NULL
is	NULL
independent	NULL
of	NULL
activation	NULL
(	NULL
18	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
importance	NULL
of	NULL
Lek	NULL
and	NULL
the	NULL
tyrosine	NULL
phosphatase	NULL
CD45	NULL
in	NULL
CD3-dependent	NULL
signal	NULL
transduction	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
these	NULL
proteins	NULL
were	NULL
required	NULL
for	NULL
CD3-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
in	NULL
vivo	NULL
using	NULL
the	NULL
Jurkat	NULL
subclones	NULL
J45.01	NULL
(	NULL
deficient	NULL
in	NULL
CD45	NULL
expression	NULL
)	NULL
and	NULL
J.Cam1	NULL
(	NULL
deficient	NULL
in	NULL
Lok	NULL
activity	NULL
)	NULL
.	NULL

The	NULL
CD3-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
was	NULL
detectable	NULL
only	NULL
in	NULL
the	NULL
Jurkat	NULL
cells	NULL
and	NULL
not	NULL
in	NULL
the	NULL
€D45-	NULL
or	NULL
Lok-deficient	NULL
Jurkat	NULL
subclones	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
6	NULL
,	NULL
10	NULL
,	NULL
and	NULL
14	NULL
)	NULL
.	NULL

Pervanadate	NULL
treatment	NULL
induced	NULL
high	NULL
levels	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
in	NULL
the	NULL
Jurkat	NULL
cells	NULL
and	NULL
detectable	NULL
amounts	NULL
of	NULL
HS1	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
the	NULL
J45.01	NULL
and	NULL
J.Cam1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
7	NULL
,	NULL
11	NULL
,	NULL
and	NULL
15	NULL
)	NULL
.	NULL

All	NULL
three	NULL
cell	NULL
lines	NULL
expressed	NULL
comparable	NULL
amounts	NULL
of	NULL
HS1	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
1-3	NULL
)	NULL
as	NULL
well	NULL
as	NULL
similar	NULL
levels	NULL
of	NULL
CD3	NULL
and	NULL
CD28	NULL
surface	NULL
expression	NULL
as	NULL
determined	NULL
by	NULL
indirect	NULL
immunofluorescence	NULL
staining	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
CD45	NULL
is	NULL
required	NULL
for	NULL
normal	NULL
Lek	NULL
activity	NULL
and	NULL
CD3-dependent	NULL
signaling	NULL
(	NULL
39	NULL
)	NULL
,	NULL
our	NULL
in	NULL
vivo	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
hypothesis	NULL
that	NULL
Lek	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
is	NULL
required	NULL
for	NULL
CD3-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
.	NULL

Phorbol	NULL
ester	NULL
treatment	NULL
inhibited	NULL
CD3-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HSI	NULL
Jurkat	NULL
T	NULL
cells	NULL
produce	NULL
IL-2	NULL
in	NULL
response	NULL
to	NULL
treatment	NULL
with	NULL
either	NULL
anti-CD3	NULL
or	NULL
anti-CD28	NULL
mAb	NULL
when	NULL
given	NULL
in	NULL
conjunction	NULL
with	NULL
low	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4510	NULL
I	NULL
A	NULL
&	NULL
.8	NULL
$	NULL
>	NULL
g	NULL
8	NULL
f	NULL
p	NULL
al	NULL
$	NULL
$	NULL
ye	NULL
0	NULL
y	NULL
x	NULL
s	NULL
I	NULL
II	NULL
I	NULL
4	NULL
tpa	NULL
Rona	NULL
F0	NULL
gor	NULL
Js	NULL
0	NULL
``	NULL
0	NULL
Stimulation	NULL
:	NULL
-	NULL
-	NULL
-__-	NULL
PPL	NULL
.	NULL

PPF	NULL
.	NULL

FPP	NULL
p	NULL
c	NULL
A	NULL
HS-1-	NULL
»	NULL
-	NULL
<	NULL
@	NULL
bemnem	NULL
»	NULL
a	NULL
;	NULL
am	NULL
am	NULL
83	NULL
1	NULL
2	NULL
3	NULL
-	NULL
4	NULL
506	NULL
7	NULL
8	NULL
910	NULL
411213	NULL
14	NULL
is	NULL
Lysates	NULL
<	NULL
--	NULL
-	NULL
aP¥	NULL
IP	NULL
's	NULL
_	NULL
--	NULL
--	NULL
»	NULL
FIGURE	NULL
5	NULL
.	NULL

Impaired	NULL
activation-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
in	NULL
cells	NULL
lacking	NULL
Lok	NULL
or	NULL
CD45	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Janes	NULL
1	NULL
and	NULL
4-7	NULL
)	NULL
,	NULL
CD45-deficient	NULL
145.01	NULL
cells	NULL
(	NULL
Janes	NULL
2	NULL
and	NULL
8-11	NULL
)	NULL
,	NULL
or	NULL
Lck-deficient	NULL
J.Cam1	NULL
cells	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
12-15	NULL
)	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
lanes	NULL
1-4	NULL
,	NULL
8	NULL
,	NULL
and	NULL
12	NULL
)	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
anti-CD28	NULL
mAb	NULL
9.3	NULL
(	NULL
Zanes	NULL
5	NULL
,	NULL
9	NULL
,	NULL
and	NULL
13	NULL
)	NULL
,	NULL
anti-CD3	NULL
mAb	NULL
OKT3	NULL
(	NULL
Zanes	NULL
6	NULL
,	NULL
10	NULL
,	NULL
and	NULL
14	NULL
)	NULL
,	NULL
or	NULL
2	NULL
uM	NULL
pervanadate	NULL
(	NULL
Zanes	NULL
7	NULL
,	NULL
11	NULL
,	NULL
and	NULL
15	NULL
)	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Proteins	NULL
in	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
cell	NULL
lysates	NULL
(	NULL
Zanes	NULL
7-3	NULL
)	NULL
or	NULL
anti-phosphotyrosine	NULL
immunoprecipitates	NULL
(	NULL
Janes	NULL
4-15	NULL
)	NULL
were	NULL
immunoblotted	NULL
with	NULL
anti-HS1	NULL
antisera	NULL
.	NULL

The	NULL
migration	NULL
patterns	NULL
of	NULL
HS1	NULL
and	NULL
molecular	NULL
mass	NULL
markers	NULL
are	NULL
indicated	NULL
.	NULL

doses	NULL
of	NULL
the	NULL
PKC-activating	NULL
phorbol	NULL
ester	NULL
,	NULL
PMA	NULL
.	NULL

We	NULL
assessed	NULL
the	NULL
effect	NULL
of	NULL
PMA	NULL
on	NULL
activation-dependent	NULL
changes	NULL
in	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
.	NULL

Anti-phosphotyrosine	NULL
immunoprecipitates	NULL
were	NULL
prepared	NULL
from	NULL
detergent	NULL
lysates	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
5	NULL
ng	NULL
PMA	NULL
for	NULL
48	NULL
h	NULL
,	NULL
conditions	NULL
used	NULL
to	NULL
enhance	NULL
the	NULL
detection	NULL
of	NULL
CD28-dependent	NULL
induction	NULL
of	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
(	NULL
40	NULL
)	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
PVDF	NULL
membranes	NULL
,	NULL
and	NULL
immunoblotted	NULL
simultaneously	NULL
with	NULL
anti-HS1	NULL
and	NULL
anti-Vav	NULL
antisera	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
PMA	NULL
pretreatment	NULL
,	NULL
stimulation	NULL
with	NULL
anti-CD28	NULL
mAb	NULL
induced	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
intracellular	NULL
signaling	NULL
protein	NULL
p95	NULL
Vav	NULL
but	NULL
not	NULL
of	NULL
HSI	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
whereas	NULL
stimulation	NULL
with	NULL
anti-CD3	NULL
mAb	NULL
induced	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
both	NULL
Vav	NULL
and	NULL
HS1	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Pretreatment	NULL
of	NULL
the	NULL
Jurkat	NULL
cells	NULL
with	NULL
PMA	NULL
for	NULL
48	NULL
h	NULL
inhibited	NULL
the	NULL
CD3-dependent	NULL
stimulation	NULL
of	NULL
HS1	NULL
phosphorylation	NULL
on	NULL
tyrosine	NULL
despite	NULL
having	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
CD3-	NULL
and	NULL
CD28-dependent	NULL
inductions	NULL
of	NULL
Vav	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
7-9	NULL
)	NULL
.	NULL

The	NULL
48-h	NULL
PMA	NULL
treatment	NULL
did	NULL
not	NULL
affect	NULL
either	NULL
Vav	NULL
or	NULL
HS1	NULL
polypep-tide	NULL
expression	NULL
as	NULL
detected	NULL
in	NULL
detergent	NULL
lysates	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
I	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Prolonged	NULL
PMA	NULL
treatment	NULL
does	NULL
not	NULL
inhibit	NULL
the	NULL
detection	NULL
of	NULL
proteins	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
through	NULL
CD28	NULL
(	NULL
40	NULL
)	NULL
.	NULL

PMA	NULL
treatment	NULL
can	NULL
alter	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
many	NULL
lymphocyte	NULL
receptors	NULL
;	NULL
CD28	NULL
expression	NULL
is	NULL
increased	NULL
,	NULL
whereas	NULL
CD3	NULL
levels	NULL
are	NULL
decreased	NULL
(	NULL
8	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
examined	NULL
ou	NULL
S	NULL
s	NULL
a	NULL
4	NULL
.	NULL

CBS	NULL
SES	NULL
Stimulation	NULL
:	NULL
_	NULL
-	NULL
_	NULL
-	NULL
--	NULL
&	NULL
&	NULL
&	NULL
8	NULL
-	NULL
&	NULL
<	NULL
9	NULL
&	NULL
48	NULL
h	NULL
PMA	NULL
:	NULL
-	NULL
-	NULL
+	NULL
soe	NULL
-	NULL
-	NULL
4	NULL
4	NULL
4	NULL
+	NULL
-~112	NULL
Vay	NULL
-	NULL
»	NULL
Pee	NULL
``	NULL
-	NULL
same	NULL
came	NULL
_-_	NULL
_	NULL
come	NULL
HS-1	NULL
-	NULL
>	NULL
»	NULL
__	NULL
«	NULL
»	NULL
asm	NULL
»	NULL
cam	NULL
-	NULL
cams	NULL
86	NULL
1°	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
FIGURE	NULL
6	NULL
.	NULL

Inhibition	NULL
of	NULL
activation-dependent	NULL
HS1	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
PMA	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
without	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
3-6	NULL
)	NULL
or	NULL
with	NULL
5	NULL
ng/ml	NULL
PMA	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
7-10	NULL
)	NULL
for	NULL
48	NULL
h.	NULL
After	NULL
harvest	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
Zanes	NULL
1-3	NULL
and	NULL
7	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
anti-CD28	NULL
mAb	NULL
9.3	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
and	NULL
10	NULL
)	NULL
or	NULL
anti-CD3	NULL
mAb	NULL
OKT3	NULL
(	NULL
lanes	NULL
5	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
and	NULL
10	NULL
)	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Proteins	NULL
in	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
cell	NULL
lysates	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
anti-phosphotyrosine	NULL
immunoprecipitates	NULL
(	NULL
Zanes	NULL
3-/0	NULL
)	NULL
were	NULL
simultaneously	NULL
immunoblotted	NULL
with	NULL
anti-HS1	NULL
antisera	NULL
and	NULL
anti-	NULL
Vav	NULL
antisera	NULL
.	NULL

HS1	NULL
AND	NULL
T	NULL
CELL	NULL
SIGNALING	NULL
acn3	NULL
eo	NULL
eg	NULL
Stimulation	NULL
:	NULL
-o	NULL
0-0	NULL
oB	NULL
c-Wis	NULL
-83	NULL
HS-1-	NULL
»	NULL
wae	NULL
=	NULL
)	NULL
sas	NULL
aHS-1	NULL
blot	NULL
-48	NULL
Erks	NULL
-	NULL
»	NULL
wise	NULL
maite	NULL
Erk	NULL
blot	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
L_	NULL
a	NULL
PY	NULL
IP	NULL
's	NULL
FIGURE	NULL
7	NULL
.	NULL

-	NULL
Differential	NULL
effects	NULL
of	NULL
the	NULL
MEK	NULL
inhibitor	NULL
and	NULL
PMA	NULL
on	NULL
the	NULL
activation-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
and	NULL
the	NULL
Erk	NULL
kinases	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
DMSO	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
10	NULL
uM	NULL
MEK	NULL
inhibitor	NULL
(	NULL
Zanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
,	NULL
or	NULL
5	NULL
ng/ml	NULL
PMA	NULL
(	NULL
Zanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
mAb	NULL
OKT3	NULL
(	NULL
Zanes	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
7	NULL
)	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Proteins	NULL
in	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
cell	NULL
lysates	NULL
(	NULL
Zane	NULL
Z	NULL
)	NULL
or	NULL
anti-phosphotyrosine	NULL
immunoprecipitates	NULL
(	NULL
Janes	NULL
2-7	NULL
)	NULL
were	NULL
immunoblotted	NULL
with	NULL
anti-HS1	NULL
antisera	NULL
(	NULL
fop	NULL
)	NULL
or	NULL
with	NULL
anti-Erk	NULL
Ab	NULL
(	NULL
bottom	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
lysate	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
corresponds	NULL
to	NULL
4	NULL
X	NULL
10°	NULL
cell	NULL
equivalents	NULL
.	NULL

The	NULL
migration	NULL
patterns	NULL
of	NULL
HS1	NULL
,	NULL
Erk	NULL
kinase	NULL
,	NULL
and	NULL
molecular	NULL
mass	NULL
markers	NULL
are	NULL
indicated	NULL
.	NULL

Lysate	NULL
whether	NULL
a	NULL
brief	NULL
pretreatment	NULL
with	NULL
PMA	NULL
affected	NULL
CD3-dependent	NULL
stimulation	NULL
of	NULL
HS1	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
pretreated	NULL
with	NULL
5	NULL
ng	NULL
PMA	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
before	NULL
stimulation	NULL
with	NULL
anti-CD3	NULL
mAb	NULL
.	NULL

The	NULL
short	NULL
incubation	NULL
with	NULL
PMA	NULL
was	NULL
sufficient	NULL
to	NULL
inhibit	NULL
most	NULL
of	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
with	NULL
either	NULL
anti-CD3	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
top	NULL
)	NULL
.	NULL

Short-term	NULL
PMA	NULL
treatment	NULL
did	NULL
not	NULL
inhibit	NULL
CD3-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p95	NULL
Vav	NULL
and	NULL
did	NULL
not	NULL
affect	NULL
expression	NULL
of	NULL
CD3	NULL
or	NULL
HS1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
both	NULL
short-	NULL
and	NULL
long-term	NULL
treatments	NULL
with	NULL
PMA	NULL
decrease	NULL
the	NULL
CD3-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
.	NULL

Furthermore	NULL
,	NULL
PKC	NULL
appears	NULL
to	NULL
regulate	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
but	NULL
not	NULL
that	NULL
of	NULL
p95	NULL
Vav	NULL
.	NULL

Activation	NULL
of	NULL
MEKI	NULL
is	NULL
not	NULL
required	NULL
for	NULL
CD3-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HSI	NULL
The	NULL
intracellular	NULL
signals	NULL
triggered	NULL
by	NULL
engagement	NULL
of	NULL
CD3	NULL
include	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
MAP	NULL
kinases	NULL
Erkl	NULL
and	NULL
Erk2	NULL
by	NULL
the	NULL
MAP	NULL
kinase	NULL
kinase	NULL
MEK1	NULL
(	NULL
9	NULL
)	NULL
.	NULL

We	NULL
used	NULL
PD98059	NULL
,	NULL
a	NULL
selective	NULL
inhibitor	NULL
of	NULL
MEK1	NULL
activation	NULL
,	NULL
to	NULL
determine	NULL
whether	NULL
this	NULL
kinase	NULL
cascade	NULL
was	NULL
required	NULL
for	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HSI	NULL
.	NULL

Stimulation	NULL
with	NULL
anti-CD3	NULL
mAb	NULL
induced	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
and	NULL
the	NULL
Erk	NULL
kinases	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lane	NULL
3	NULL
,	NULL
top	NULL
and	NULL
bottom	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Pretreatment	NULL
of	NULL
the	NULL
cells	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
with	NULL
10	NULL
jM	NULL
of	NULL
the	NULL
MEK1	NULL
inhibitor	NULL
was	NULL
sufficient	NULL
to	NULL
inhibit	NULL
more	NULL
than	NULL
70	NULL
%	NULL
of	NULL
the	NULL
Erk	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lane	NULL
5	NULL
,	NULL
bottom	NULL
)	NULL
without	NULL
diminishing	NULL
the	NULL
HS1	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lane	NULL
5	NULL
,	NULL
top	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
PMA	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
inhibited	NULL
the	NULL
CD3-dependent	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
,	NULL
top	NULL
)	NULL
,	NULL
and	NULL
PMA	NULL
treatment	NULL
alone	NULL
was	NULL
able	NULL
to	NULL
stimulate	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
Erk	NULL
kinases	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
,	NULL
bottom	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
after	NULL
CD3	NULL
ligation	NULL
is	NULL
not	NULL
dependent	NULL
upon	NULL
the	NULL
activation	NULL
of	NULL
MEK1	NULL
or	NULL
its	NULL
downstream	NULL
effector	NULL
molecules	NULL
.	NULL

Discussion	NULL
Ligation	NULL
of	NULL
the	NULL
TCR/CD3	NULL
complex	NULL
induces	NULL
the	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

HS1	NULL
phosphorylation	NULL
required	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
Sre	NULL
family	NULL
kinase	NULL
Lock	NULL
:	NULL
we	NULL
did	NULL
not	NULL
find	NULL
CD3-dependent	NULL
HS1	NULL
phosphorylation	NULL
in	NULL
Jurkat	NULL
cells	NULL
rendered	NULL
genetically	NULL
deficient	NULL
in	NULL
Lok	NULL
kinase	NULL
activity	NULL
or	NULL
in	NULL
€D45	NULL
phosphatase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
a	NULL
recent	NULL
report	NULL
that	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
CD45-null	NULL
thymocytes	NULL
also	NULL
show	NULL
impaired	NULL
CD3-dependent	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
activation	NULL
of	NULL
Lek	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
induction	NULL
of	NULL
HS1	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
vivo	NULL
.	NULL

We	NULL
found	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
was	NULL
not	NULL
detected	NULL
after	NULL
engagement	NULL
of	NULL
CD28	NULL
or	NULL
CD2	NULL
,	NULL
despite	NULL
the	NULL
ability	NULL
of	NULL
these	NULL
receptors	NULL
to	NULL
activate	NULL
Leck	NULL
and	NULL
other	NULL
Sre	NULL
family	NULL
tyrosine	NULL
kinases	NULL
(	NULL
42-47	NULL
)	NULL
.	NULL

Engagement	NULL
of	NULL
CD3	NULL
,	NULL
but	NULL
not	NULL
CD28	NULL
or	NULL
CD2	NULL
,	NULL
activates	NULL
the	NULL
Syk	NULL
family	NULL
tyrosine	NULL
kinase	NULL
ZAP7O	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
whereby	NULL
CD3-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
requires	NULL
the	NULL
dual	NULL
activation	NULL
of	NULL
both	NULL
ZAP70	NULL
and	NULL
Lek	NULL
,	NULL
a	NULL
synergy	NULL
that	NULL
is	NULL
not	NULL
recruited	NULL
by	NULL
either	NULL
the	NULL
CD28	NULL
or	NULL
CD2	NULL
receptor	NULL
.	NULL

This	NULL
model	NULL
is	NULL
supported	NULL
by	NULL
reports	NULL
that	NULL
Syk	NULL
and	NULL
the	NULL
Src	NULL
family	NULL
kinase	NULL
Lyn	NULL
are	NULL
both	NULL
required	NULL
for	NULL
HS1	NULL
phosphorylation	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
23	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
engagement	NULL
of	NULL
the	NULL
CD28	NULL
and/or	NULL
CD2	NULL
costimulatory	NULL
receptors	NULL
may	NULL
differentially	NULL
activate	NULL
protein	NULL
tyrosine	NULL
phosphatases	NULL
,	NULL
thereby	NULL
inhibiting	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
SHP2	NULL
can	NULL
associate	NULL
with	NULL
the	NULL
CD28	NULL
family	NULL
member	NULL
CTLA-4	NULL
(	NULL
50	NULL
)	NULL
and	NULL
CD45	NULL
can	NULL
associate	NULL
with	NULL
CD2	NULL
(	NULL
51	NULL
,	NULL
52	NULL
)	NULL
.	NULL

However	NULL
,	NULL
simultaneous	NULL
stimulation	NULL
of	NULL
CD3	NULL
and	NULL
CD28	NULL
or	NULL
CD2	NULL
did	NULL
not	NULL
diminish	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
tyrosine	NULL
phosphatase	NULL
,	NULL
if	NULL
one	NULL
exists	NULL
,	NULL
is	NULL
not	NULL
dominant	NULL
under	NULL
these	NULL
conditions	NULL
.	NULL

We	NULL
also	NULL
found	NULL
that	NULL
activation	NULL
of	NULL
PKC	NULL
by	NULL
PMA	NULL
treatment	NULL
preferentially	NULL
inhibited	NULL
the	NULL
CD3-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
but	NULL
not	NULL
that	NULL
of	NULL
Vav	NULL
.	NULL

PMA	NULL
has	NULL
multiple	NULL
effects	NULL
on	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
(	NULL
53	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
inhibition	NULL
of	NULL
Lek	NULL
activity	NULL
by	NULL
PMA	NULL
causes	NULL
the	NULL
inhibition	NULL
of	NULL
HS1	NULL
phos-phorylation	NULL
,	NULL
since	NULL
the	NULL
CD3-induced	NULL
phosphorylation	NULL
of	NULL
Vav	NULL
is	NULL
also	NULL
dependent	NULL
upon	NULL
Lock	NULL
(	NULL
54	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
HS1	NULL
and	NULL
Vav	NULL
are	NULL
differentially	NULL
regulated	NULL
by	NULL
PKC	NULL
downstream	NULL
of	NULL
Leck	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
phorbol	NULL
ester	NULL
treatment	NULL
induces	NULL
the	NULL
serine/threonine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
,	NULL
preventing	NULL
its	NULL
interaction	NULL
with	NULL
Lok	NULL
.	NULL

The	NULL
proline-rich	NULL
region	NULL
of	NULL
HS1	NULL
,	NULL
required	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
SH3	NULL
domain	NULL
of	NULL
Lock	NULL
,	NULL
contains	NULL
a	NULL
potential	NULL
consensus	NULL
site	NULL
for	NULL
phosphorylation	NULL
by	NULL
proline-directed	NULL
serine/threonine	NULL
kinases	NULL
(	NULL
18	NULL
)	NULL
activated	NULL
by	NULL
phorbol	NULL
esters	NULL
.	NULL

Alternatively	NULL
,	NULL
PMA	NULL
may	NULL
inhibit	NULL
activation	NULL
of	NULL
a	NULL
required	NULL
intermediate	NULL
such	NULL
as	NULL
a	NULL
Syk	NULL
family	NULL
kinase	NULL
or	NULL
modify	NULL
the	NULL
intracellular	NULL
localization	NULL
of	NULL
HS1	NULL
or	NULL
its	NULL
partner	NULL
proteins	NULL
.	NULL

Importantly	NULL
,	NULL
our	NULL
studies	NULL
indicate	NULL
that	NULL
activation-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
is	NULL
not	NULL
required	NULL
for	NULL
NFAT	NULL
transcriptional	NULL
activation	NULL
.	NULL

NFAT	NULL
proteins	NULL
are	NULL
transcriptional	NULL
regulators	NULL
of	NULL
critical	NULL
immune	NULL
response	NULL
genes	NULL
,	NULL
including	NULL
IL-2	NULL
.	NULL

There	NULL
was	NULL
no	NULL
detectable	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
after	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
mitogenic	NULL
pairs	NULL
of	NULL
CD2	NULL
mAbs	NULL
,	NULL
conditions	NULL
sufficient	NULL
for	NULL
NFAT	NULL
luciferase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
and	NULL
IL-2	NULL
production	NULL
(	NULL
5	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
CD3-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
was	NULL
not	NULL
diminished	NULL
by	NULL
incubation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
cyclosporine	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
a	NULL
calcineurin	NULL
inhibitor	NULL
that	NULL
prevents	NULL
the	NULL
nuclear	NULL
translocation	NULL
and	NULL
transcriptional	NULL
activation	NULL
of	NULL
NFAT	NULL
(	NULL
55	NULL
,	NULL
56	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
appears	NULL
to	NULL
be	NULL
independent	NULL
of	NULL
the	NULL
calcium	NULL
arm	NULL
of	NULL
CD3-dependent	NULL
signaling	NULL
,	NULL
which	NULL
involves	NULL
the	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
Fyn	NULL
and	NULL
Itk	NULL
(	NULL
57	NULL
,	NULL
58	NULL
)	NULL
.	NULL

We	NULL
also	NULL
found	NULL
that	NULL
inhibition	NULL
of	NULL
MEK	NULL
1	NULL
activity	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
CD3-dependent	NULL
HS1	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
neither	NULL
MEK	NULL
1	NULL
nor	NULL
its	NULL
downstream	NULL
effectors	NULL
are	NULL
directly	NULL
required	NULL
for	NULL
activation-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
.	NULL

Moreover	NULL
,	NULL
since	NULL
MEK	NULL
1	NULL
activation	NULL
of	NULL
the	NULL
Erk	NULL
kinases	NULL
is	NULL
an	NULL
important	NULL
step	NULL
in	NULL
CD3-dependent	NULL
IL-2	NULL
production	NULL
,	NULL
this	NULL
finding	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
hypothesis	NULL
that	NULL
regulation	NULL
of	NULL
cytokine	NULL
production	NULL
is	NULL
not	NULL
a	NULL
primary	NULL
function	NULL
of	NULL
HS1	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
it	NULL
is	NULL
intriguing	NULL
that	NULL
HS1	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
apoptotic	NULL
signaling	NULL
pathways	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
although	NULL
a	NULL
comparable	NULL
effect	NULL
in	NULL
T	NULL
cells	NULL
remains	NULL
to	NULL
be	NULL
established	NULL
.	NULL

In	NULL
B	NULL
cells	NULL
,	NULL
HS1	NULL
can	NULL
bind	NULL
to	NULL
HAX-1	NULL
,	NULL
a	NULL
35-kDa	NULL
protein	NULL
that	NULL
shares	NULL
sequence	NULL
similarities	NULL
with	NULL
Bcel-2	NULL
family	NULL
members	NULL
and	NULL
colocalizes	NULL
4511	NULL
with	NULL
Bcl-x	NULL
,	NULL
in	NULL
the	NULL
mitochondria	NULL
(	NULL
59	NULL
)	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
survival	NULL
signal	NULL
transmitted	NULL
even	NULL
though	NULL
CD28	NULL
involves	NULL
the	NULL
up-regulation	NULL
of	NULL
Bcel-x	NULL
,	NULL
,	NULL
expression	NULL
and	NULL
function	NULL
.	NULL

Whether	NULL
Bcel-x	NULL
,	NULL
,	NULL
could	NULL
in	NULL
turn	NULL
modulate	NULL
a	NULL
CD3-dependent	NULL
apoptotic	NULL
pathway	NULL
mediated	NULL
by	NULL
the	NULL
interaction	NULL
of	NULL
HS1	NULL
and	NULL
HAX-1	NULL
in	NULL
T	NULL
lymphocytes	NULL
remains	NULL
to	NULL
be	NULL
tested	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
T.	NULL
Roberts	NULL
,	NULL
E.	NULL
L.	NULL
Reinherz	NULL
,	NULL
J.	NULL
Blenis	NULL
,	NULL
and	NULL
L.	NULL
Glimcher	NULL
for	NULL
reagents	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Schwartz	NULL
,	NULL
R.	NULL
H.	NULL
1990	NULL
.	NULL

A	NULL
cell	NULL
culture	NULL
model	NULL
for	NULL
T	NULL
lymphocyte	NULL
clonal	NULL
anergy	NULL
.	NULL

Science	NULL
248:1349	NULL
.	NULL

2	NULL
.	NULL

Schwartz	NULL
,	NULL
R.	NULL
H.	NULL
1992	NULL
.	NULL

Costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
:	NULL
the	NULL
role	NULL
of	NULL
CD28	NULL
,	NULL
CTLA-4	NULL
,	NULL
and	NULL
B7/BB1	NULL
in	NULL
interleukin-2	NULL
production	NULL
and	NULL
immunotherapy	NULL
.	NULL

Cell	NULL
77	NULL
:	NULL
1065	NULL
.	NULL

3	NULL
.	NULL

June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
,	NULL
L.	NULL
M.	NULL
Nadler	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
B7	NULL
and	NULL
CD28	NULL
receptor	NULL
families	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
15:321	NULL
.	NULL

4	NULL
.	NULL

Bluestone	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

1995	NULL
.	NULL

New	NULL
perspectives	NULL
of	NULL
CD28-B7-mediated	NULL
T	NULL
cell	NULL
costimulation	NULL
.	NULL

Immunity	NULL
2:555	NULL
.	NULL

5	NULL
.	NULL

Bierer	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Hahn	NULL
.	NULL

1993	NULL
.	NULL

T	NULL
cell	NULL
adhesion	NULL
,	NULL
avidity	NULL
regulation	NULL
,	NULL
and	NULL
signaling	NULL
:	NULL
a	NULL
molecular	NULL
analysis	NULL
of	NULL
CD2	NULL
.	NULL

Semin	NULL
.	NULL

Immunol	NULL
.	NULL

5:249	NULL
.	NULL

6	NULL
.	NULL

Boussiotis	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
J.	NULL
G.	NULL
Gribben	NULL
,	NULL
G.	NULL
J.	NULL
Freeman	NULL
,	NULL
and	NULL
L.	NULL
M.	NULL
Nadler	NULL
.	NULL

1994	NULL
.	NULL

Blockade	NULL
of	NULL
the	NULL
CD28	NULL
co-stimulatory	NULL
pathway	NULL
:	NULL
a	NULL
means	NULL
to	NULL
induce	NULL
tolerance	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

6:797	NULL
.	NULL

7	NULL
.	NULL

June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
P.	NULL
S.	NULL
Linsley	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1990	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
CD28	NULL
receptor	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
11:211	NULL
.	NULL

8	NULL
.	NULL

Linsley	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
CD28	NULL
receptor	NULL
during	NULL
T	NULL
cell	NULL
responses	NULL
to	NULL
antigen	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

11:191	NULL
.	NULL

9	NULL
.	NULL

Cantrell	NULL
,	NULL
D.	NULL
1996	NULL
.	NULL

T	NULL
cell	NULL
antigen	NULL
receptor	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:259	NULL
.	NULL

10	NULL
.	NULL

Hutchcroft	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
and	NULL
B.	NULL
E.	NULL
Bierer	NULL
.	NULL

1996	NULL
.	NULL

Signaling	NULL
through	NULL
CD28/CTLA-4	NULL
family	NULL
receptors	NULL
:	NULL
puzzling	NULL
participation	NULL
of	NULL
phosphatidylinositol-3	NULL
kinase	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:4071	NULL
.	NULL

11	NULL
.	NULL

Alberola-Ila	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
Takaki	NULL
,	NULL
J.	NULL
D.	NULL
Kerner	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Perlmutter	NULL
.	NULL

1997	NULL
.	NULL

Differential	NULL
signaling	NULL
by	NULL
lymphocyte	NULL
antigen	NULL
receptors	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15:125	NULL
.	NULL

12	NULL
.	NULL

Ward	NULL
,	NULL
S.	NULL
G.	NULL
1996	NULL
.	NULL

CD28	NULL
:	NULL
a	NULL
signalling	NULL
perspective	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

318:361	NULL
.	NULL

13	NULL
.	NULL

Boise	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
A.	NULL
J.	NULL
Minn	NULL
,	NULL
P.	NULL
J.	NULL
Noel	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
M.	NULL
A.	NULL
Accavitti	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1995	NULL
.	NULL

CD28	NULL
costimulation	NULL
can	NULL
promote	NULL
T	NULL
cell	NULL
survival	NULL
by	NULL
enhancing	NULL
the	NULL
expression	NULL
of	NULL
Bcl-XL	NULL
.	NULL

Immunity	NULL
3:87	NULL
.	NULL

14	NULL
.	NULL

Collette	NULL
,	NULL
Y.	NULL
,	NULL
D.	NULL
Razanajaona	NULL
,	NULL
M.	NULL
Ghiotto	NULL
,	NULL
and	NULL
D.	NULL
Olive	NULL
.	NULL

1997	NULL
.	NULL

CD28	NULL
can	NULL
promote	NULL
T	NULL
cell	NULL
survival	NULL
through	NULL
a	NULL
phosphatidylinositol-3-kinase	NULL
independent	NULL
mechanism	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

27:3283	NULL
.	NULL

15	NULL
.	NULL

Kitamura	NULL
,	NULL
D.	NULL
,	NULL
H.	NULL
Kaneko	NULL
,	NULL
Y.	NULL
Miyagoc	NULL
,	NULL
T.	NULL
Ariyasu	NULL
,	NULL
and	NULL
T.	NULL
Watanabe	NULL
.	NULL

1989	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
novel	NULL
human	NULL
gene	NULL
expressed	NULL
specifically	NULL
in	NULL
the	NULL
cells	NULL
of	NULL
hematopoictic	NULL
lineage	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:9367	NULL
.	NULL

16	NULL
.	NULL

Yamanashi	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
Okada	NULL
,	NULL
T.	NULL
Semba	NULL
,	NULL
T.	NULL
Yamori	NULL
,	NULL
H.	NULL
Umemori	NULL
,	NULL
S.	NULL
Tsunasawa	NULL
,	NULL
K.	NULL
Toyoshima	NULL
,	NULL
D.	NULL
Kitamura	NULL
,	NULL
T.	NULL
Watanabe	NULL
,	NULL
and	NULL
T.	NULL
Yamamoto	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
HS1	NULL
protein	NULL
as	NULL
a	NULL
major	NULL
substrate	NULL
of	NULL
protein-tyrosine	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
upon	NULL
B-cell	NULL
antigen	NULL
receptor-mediated	NULL
signaling	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:3631	NULL
.	NULL

17	NULL
.	NULL

Fukamachi	NULL
,	NULL
H.	NULL
,	NULL
N.	NULL
Yamada	NULL
,	NULL
T.	NULL
Miura	NULL
,	NULL
T.	NULL
Kato	NULL
,	NULL
M.	NULL
Ishikawa	NULL
,	NULL
E.	NULL
Gulbins	NULL
,	NULL
A.	NULL
Altman	NULL
,	NULL
Y.	NULL
Kawakami	NULL
,	NULL
and	NULL
T.	NULL
Kawakami	NULL
.	NULL

1994	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
protein	NULL
,	NULL
SPY75	NULL
,	NULL
with	NULL
repetitive	NULL
helix-turn-helix	NULL
motifs	NULL
and	NULL
an	NULL
SH3	NULL
domain	NULL
as	NULL
a	NULL
major	NULL
substrate	NULL
for	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
activated	NULL
by	NULL
FceRI	NULL
cross-linking	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:642	NULL
.	NULL

18	NULL
.	NULL

Takemoto	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
Furuta	NULL
,	NULL
X.-K.	NULL
Li	NULL
,	NULL
W.	NULL
J.	NULL
Strong-Sparks	NULL
,	NULL
and	NULL
Y.	NULL
Hashimoto	NULL
.	NULL

1995	NULL
.	NULL

LckBP1	NULL
,	NULL
a	NULL
proline-rich	NULL
protein	NULL
expressed	NULL
in	NULL
haematopoietic	NULL
lineage	NULL
cells	NULL
,	NULL
directly	NULL
associates	NULL
with	NULL
the	NULL
SH3	NULL
domain	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
p56lck	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:3403	NULL
.	NULL

19	NULL
.	NULL

Miglarese	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
J.	NULL
Mannion-Henderson	NULL
,	NULL
H.	NULL
We	NULL
,	NULL
J.	NULL
T.	NULL
Parsons	NULL
,	NULL
and	NULL
T.	NULL
P.	NULL
Bender	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
substrate	NULL
cortactin	NULL
is	NULL
differentially	NULL
expressed	NULL
in	NULL
murine	NULL
B	NULL
lymphoid	NULL
tumors	NULL
.	NULL

Oncogene	NULL
9:1989	NULL
.	NULL

20	NULL
.	NULL

Fukuda	NULL
,	NULL
T.	NULL
,	NULL
D.	NULL
Kitamura	NULL
,	NULL
I.	NULL
Taniuchi	NULL
,	NULL
Y.	NULL
Mackawa	NULL
,	NULL
L.	NULL
E.	NULL
Benhamou	NULL
,	NULL
P.	NULL
Sarthou	NULL
,	NULL
and	NULL
T.	NULL
Watanabe	NULL
.	NULL

1995	NULL
.	NULL

Restoration	NULL
of	NULL
surface	NULL
IgM-mediated	NULL
apoptosis	NULL
in	NULL
an	NULL
anti-IgM-resistant	NULL
variant	NULL
of	NULL
WEHI-231	NULL
lymphoma	NULL
cells	NULL
by	NULL
HS1	NULL
,	NULL
a	NULL
protein-tyrosine	NULL
kinase	NULL
substrate	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:7302	NULL
.	NULL

21	NULL
.	NULL

Taniuchi	NULL
,	NULL
L.	NULL
,	NULL
D.	NULL
Kitamura	NULL
,	NULL
Y.	NULL
Mackawa	NULL
,	NULL
T.	NULL
Fukuda	NULL
,	NULL
H.	NULL
Kishi	NULL
,	NULL
and	NULL
T.	NULL
Watanabe	NULL
.	NULL

1995	NULL
.	NULL

Antigen-receptor	NULL
induced	NULL
clonal	NULL
expansion	NULL
and	NULL
deletion	NULL
of	NULL
lymphocytes	NULL
are	NULL
impaired	NULL
in	NULL
mice	NULL
lacking	NULL
HS1	NULL
protein	NULL
,	NULL
a	NULL
substrate	NULL
of	NULL
the	NULL
antigen-receptor-coupled	NULL
tyrosine	NULL
kinases	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:3664	NULL
.	NULL

22	NULL
.	NULL

Nishizumi	NULL
,	NULL
H.	NULL
,	NULL
I	NULL
Taniuchi	NULL
,	NULL
Y.	NULL
Yamanashi	NULL
,	NULL
D.	NULL
Kitamura	NULL
,	NULL
D.	NULL
Ilic	NULL
,	NULL
S.	NULL
Mori	NULL
,	NULL
T.	NULL
Watanabe	NULL
,	NULL
and	NULL
T.	NULL
Yamamoto	NULL
.	NULL

1995	NULL
.	NULL

Impaired	NULL
proliferation	NULL
of	NULL
peripheral	NULL
B	NULL
cells	NULL
and	NULL
indication	NULL
of	NULL
autoimmune	NULL
disease	NULL
in	NULL
Lyn-deficient	NULL
mice	NULL
.	NULL

Immunity	NULL
3:549	NULL
.	NULL

23	NULL
.	NULL

Yamanashi	NULL
,	NULL
Y.	NULL
,	NULL
T.	NULL
Fukuda	NULL
,	NULL
H.	NULL
Nishizumi	NULL
,	NULL
T.	NULL
Inazu	NULL
,	NULL
K.	NULL
Higashi	NULL
,	NULL
D.	NULL
Kitamura	NULL
,	NULL
T.	NULL
Ishida	NULL
,	NULL
H.	NULL
Yamamura	NULL
,	NULL
T.	NULL
Watanabe	NULL
,	NULL
and	NULL
T.	NULL
Yamamoto	NULL
.	NULL

1997	NULL
.	NULL

Role	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
in	NULL
B	NULL
cell	NULL
antigen	NULL
receptor-mediated	NULL
apoptosis	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:1387	NULL
.	NULL

24	NULL
.	NULL

Remold-O'Donnell	NULL
,	NULL
E.	NULL
,	NULL
D.	NULL
M.	NULL
Kenney	NULL
,	NULL
R.	NULL
Parkman	NULL
,	NULL
L.	NULL
Cairns	NULL
,	NULL
B	NULL
.	NULL

Savage	NULL
,	NULL
and	NULL
F.	NULL
S.	NULL
Rosen	NULL
.	NULL

1984	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
human	NULL
lymphocyte	NULL
surface	NULL
sialoglyco-protein	NULL
that	NULL
is	NULL
defective	NULL
in	NULL
Wiskott-Aldrich	NULL
syndrome	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

159:1705	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4512	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

Berard	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
W.	NULL
Knowles	NULL
,	NULL
K.	NULL
Naito	NULL
,	NULL
B.	NULL
Dupont	NULL
,	NULL
B.	NULL
Raynal	NULL
,	NULL
H.	NULL
C.	NULL
Tran	NULL
,	NULL
and	NULL
L.	NULL
Boumsell	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
unique	NULL
epitope	NULL
on	NULL
the	NULL
CD2	NULL
molecule	NULL
defined	NULL
by	NULL
the	NULL
mono-clonal	NULL
antibody	NULL
9-1	NULL
:	NULL
epitope-specific	NULL
modulation	NULL
of	NULL
the	NULL
E-rosette	NULL
receptor	NULL
and	NULL
effects	NULL
on	NULL
T-cell	NULL
functions	NULL
.	NULL

Hum	NULL
.	NULL

Immunol	NULL
.	NULL

17:388	NULL
.	NULL

Martin	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
G.	NULL
Longton	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
W.	NULL
Newman	NULL
,	NULL
M.	NULL
P.	NULL
Braun	NULL
,	NULL
P.	NULL
G.	NULL
Beatty	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Hansen	NULL
.	NULL

1983	NULL
.	NULL

Identification	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
two	NULL
distinct	NULL
epitopes	NULL
on	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
surface	NULL
protein	NULL
Tp50	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

131:180	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Y.	NULL
L.	NULL
Sun	NULL
,	NULL
L.	NULL
H.	NULL
Glimcher	NULL
,	NULL
and	NULL
T.	NULL
Hoey	NULL
.	NULL

1995	NULL
.	NULL

Novel	NULL
NFAT	NULL
sites	NULL
that	NULL
mediate	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
T	NULL
cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:6299	NULL
.	NULL

Baumann	NULL
,	NULL
G.	NULL
,	NULL
D.	NULL
Maier	NULL
,	NULL
F.	NULL
Freuler	NULL
,	NULL
C.	NULL
Tschopp	NULL
,	NULL
K.	NULL
Baudisch	NULL
,	NULL
and	NULL
J.	NULL
Wicnands	NULL
.	NULL

1994	NULL
.	NULL

In	NULL
vitro	NULL
characterization	NULL
of	NULL
major	NULL
ligands	NULL
for	NULL
Src	NULL
homology	NULL
2	NULL
domains	NULL
derived	NULL
from	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
,	NULL
from	NULL
the	NULL
adapter	NULL
protein	NULL
SHC	NULL
and	NULL
from	NULL
GTPase-activating	NULL
protein	NULL
in	NULL
Ramos	NULL
B	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

24:1799	NULL
.	NULL

Nunes	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Y.	NULL
Collette	NULL
,	NULL
A.	NULL
Trunch	NULL
,	NULL
D.	NULL
Olive	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
role	NULL
of	NULL
p21	NULL
Ras	NULL
in	NULL
CD28	NULL
signal	NULL
transduction	NULL
:	NULL
triggering	NULL
of	NULL
CD28	NULL
with	NULL
antibodies	NULL
,	NULL
but	NULL
not	NULL
the	NULL
ligand	NULL
B7-1	NULL
,	NULL
activates	NULL
p21	NULL
Ras	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:1067	NULL
.	NULL

Hutchcroft	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
D.	NULL
P.	NULL
Franklin	NULL
,	NULL
B.	NULL
Tsai	NULL
,	NULL
D.	NULL
Harrison-Findik	NULL
,	NULL
L.	NULL
Varticovski	NULL
,	NULL
and	NULL
B.	NULL
E.	NULL
Bierer	NULL
.	NULL

1995	NULL
.	NULL

Phorbol	NULL
ester	NULL
treatment	NULL
inhibits	NULL
phosphatidylinositol	NULL
3-kinase	NULL
activation	NULL
by	NULL
and	NULL
association	NULL
with	NULL
CD28	NULL
,	NULL
a	NULL
T-lymphocyte	NULL
surface	NULL
receptor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:8808	NULL
.	NULL

Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
P.	NULL
J.	NULL
Utz	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
J.	NULL
J.	NULL
Toole	NULL
,	NULL
E.	NULL
A.	NULL
Emmel	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
putative	NULL
regulator	NULL
of	NULL
early	NULL
T	NULL
cell	NULL
activation	NULL
genes	NULL
.	NULL

Science	NULL
241:202	NULL
.	NULL

Bierer	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
B.	NULL
P.	NULL
Sleckman	NULL
,	NULL
S.	NULL
E.	NULL
Ratnofsky	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Burakoff	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
biologic	NULL
roles	NULL
of	NULL
CD2	NULL
,	NULL
CD4	NULL
,	NULL
and	NULL
CD8	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

7:579	NULL
.	NULL

Hiinig	NULL
,	NULL
T.	NULL
,	NULL
G.	NULL
Ticfenthaler	NULL
,	NULL
K.-H.	NULL
Meyer	NULL
zum	NULL
Biischenfelde	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Meuer	NULL
.	NULL

1987	NULL
.	NULL

Alternative	NULL
pathway	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
binding	NULL
of	NULL
CD2	NULL
to	NULL
its	NULL
cell	NULL
surface	NULL
ligand	NULL
.	NULL

Nature	NULL
326:298	NULL
.	NULL

Ohno	NULL
,	NULL
H.	NULL
,	NULL
C.	NULL
Ushiyama	NULL
,	NULL
M.	NULL
Taniguichi	NULL
,	NULL
R.	NULL
N.	NULL
Germain	NULL
,	NULL
and	NULL
T.	NULL
Saito	NULL
.	NULL

1991	NULL
.	NULL

CD2	NULL
can	NULL
mediate	NULL
TCR/CD3-independent	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:3742	NULL
.	NULL

Howard	NULL
,	NULL
F.	NULL
D.	NULL
,	NULL
P.	NULL
Moingeon	NULL
,	NULL
U.	NULL
Moebius	NULL
,	NULL
D.	NULL
J.	NULL
McConkey	NULL
,	NULL
B.	NULL
Yandava	NULL
,	NULL
T.	NULL
E.	NULL
Gennert	NULL
,	NULL
and	NULL
E.	NULL
L.	NULL
Reinherz	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
CD3¢	NULL
cytoplasmic	NULL
domain	NULL
mediates	NULL
CD2-induced	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176:139	NULL
.	NULL

Takemoto	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
Sato	NULL
,	NULL
M.	NULL
Furuta	NULL
,	NULL
and	NULL
Y.	NULL
Hashimoto	NULL
.	NULL

1996	NULL
.	NULL

Distinct	NULL
binding	NULL
patterns	NULL
of	NULL
HS1	NULL
to	NULL
the	NULL
Src	NULL
SH2	NULL
and	NULL
SH3	NULL
domains	NULL
reflect	NULL
possible	NULL
mechanisms	NULL
of	NULL
recruitment	NULL
and	NULL
activation	NULL
of	NULL
downstream	NULL
molecules	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

8:1699	NULL
.	NULL

Perlmutter	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
S.	NULL
D.	NULL
Levin	NULL
,	NULL
M.	NULL
W.	NULL
Appleby	NULL
,	NULL
S.	NULL
J.	NULL
Anderson	NULL
,	NULL
and	NULL
J.	NULL
Alberola-Ila	NULL
.	NULL

1993	NULL
.	NULL

Regulation	NULL
of	NULL
lymphocyte	NULL
function	NULL
by	NULL
protein	NULL
phosphorylation	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

11:451	NULL
.	NULL

Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
D.	NULL
M.	NULL
Desai	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
role	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
and	NULL
protein	NULL
tyrosine	NULL
phosphatases	NULL
in	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
signal	NULL
trans-duction	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:555	NULL
.	NULL

Koretzky	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
J.	NULL
Picus	NULL
,	NULL
T.	NULL
Schutz	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1991	NULL
.	NULL

Tyrosine	NULL
phosphatase	NULL
CD45	NULL
is	NULL
required	NULL
for	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
and	NULL
CD2-mediated	NULL
activation	NULL
of	NULL
a	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
and	NULL
interleukin	NULL
2	NULL
production	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:2037	NULL
.	NULL

Vandenberghe	NULL
,	NULL
P.	NULL
,	NULL
F.	NULL
J.	NULL
Freeman	NULL
,	NULL
L.	NULL
M.	NULL
Nadler	NULL
,	NULL
M.	NULL
C.	NULL
Fletcher	NULL
,	NULL
M.	NULL
Kamoun	NULL
,	NULL
L.	NULL
A.	NULL
Turka	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
and	NULL
C.	NULL
H.	NULL
June	NULL
.	NULL

1992	NULL
.	NULL

Antibody	NULL
and	NULL
B7/BB1-mediated	NULL
ligation	NULL
of	NULL
the	NULL
CD28	NULL
receptor	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

£xp	NULL
.	NULL

Med	NULL
.	NULL

175:951	NULL
.	NULL

Stone	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
L.	NULL
A.	NULL
Conroy	NULL
,	NULL
K.	NULL
F.	NULL
Byth	NULL
,	NULL
R.	NULL
A.	NULL
Hederer	NULL
,	NULL
S.	NULL
Howlett	NULL
,	NULL
Y.	NULL
Takemoto	NULL
,	NULL
N.	NULL
Holmes	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Alexander	NULL
.	NULL

1997	NULL
.	NULL

Aberrant	NULL
TCR-mediated	NULL
signaling	NULL
in	NULL
42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

HS1	NULL
AND	NULL
T	NULL
CELL	NULL
SIGNALING	NULL
CD45-null	NULL
thymocytes	NULL
involves	NULL
dysfunctional	NULL
regulation	NULL
of	NULL
Lok	NULL
,	NULL
Fyn	NULL
,	NULL
TCR-f	NULL
,	NULL
and	NULL
ZAP-70	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:5773	NULL
.	NULL

Hutchcroft	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
and	NULL
B.	NULL
E.	NULL
Bierer	NULL
.	NULL

1994	NULL
.	NULL

Activation-dependent	NULL
phosphorylation	NULL
of	NULL
the	NULL
T-lymphocyte	NULL
surface	NULL
receptor	NULL
CD28	NULL
and	NULL
associated	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:3260	NULL
.	NULL

August	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
B.	NULL
Dupont	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
src	NULL
family	NULL
kinase	NULL
Ick	NULL
following	NULL
CD28	NULL
crosslinking	NULL
in	NULL
the	NULL
Jurkat	NULL
leukemic	NULL
cell	NULL
line	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Com-mun	NULL
.	NULL

199	NULL
;	NULL
:1466	NULL
.	NULL

Raab	NULL
,	NULL
M.	NULL
,	NULL
Y.-C.	NULL
Cai	NULL
,	NULL
S.	NULL
C.	NULL
Bunnell	NULL
,	NULL
S.	NULL
D.	NULL
Heyeck	NULL
,	NULL
L.	NULL
J.	NULL
Berg	NULL
,	NULL
and	NULL
C.	NULL
E.	NULL
Rudd	NULL
.	NULL

1995.	NULL
p56	NULL
Lck	NULL
and	NULL
p59	NULL
Fyn	NULL
regulate	NULL
CD28	NULL
binding	NULL
to	NULL
phosphatidylinositol	NULL
3-kinase	NULL
,	NULL
growth	NULL
factor	NULL
receptor-bound	NULL
protein	NULL
GRB-2	NULL
,	NULL
and	NULL
T	NULL
cell-specific	NULL
protein-tyrosine	NULL
ITK	NULL
:	NULL
implications	NULL
for	NULL
T-cell	NULL
costimulation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:8891	NULL
.	NULL

Danielian	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Pagard	NULL
,	NULL
A.	NULL
Alcover	NULL
,	NULL
O.	NULL
Acuto	NULL
,	NULL
and	NULL
S.	NULL
Fischer	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
lym-phocyte-specific	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
p56	NULL
Lck	NULL
is	NULL
hyperphosphorylated	NULL
on	NULL
serine	NULL
and	NULL
tyrosine	NULL
residues	NULL
within	NULL
minutes	NULL
after	NULL
activation	NULL
via	NULL
T	NULL
cell	NULL
receptor	NULL
or	NULL
CD2	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

19:2183	NULL
.	NULL

Danielian	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Fagard	NULL
,	NULL
A.	NULL
Alcover	NULL
,	NULL
O.	NULL
Acuto	NULL
,	NULL
and	NULL
S.	NULL
Fischer	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
of	NULL
p56	NULL
Lok	NULL
is	NULL
increased	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
activated	NULL
via	NULL
CD2	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

21:1967	NULL
.	NULL

Bell	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Bolen	NULL
,	NULL
and	NULL
J	NULL
.	NULL

B.	NULL
Imboden	NULL
.	NULL

1992	NULL
.	NULL

Association	NULL
of	NULL
src-like	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
with	NULL
the	NULL
CD2	NULL
cell	NULL
surface	NULL
molecule	NULL
in	NULL
rat	NULL
T	NULL
lymphocytes	NULL
and	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:5548	NULL
.	NULL

Howe	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1995	NULL
.	NULL

Multiple	NULL
kinases	NULL
mediate	NULL
T	NULL
cell	NULL
receptor	NULL
signaling	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

20:59	NULL
.	NULL

Ruzzene	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
M.	NULL
Brunati	NULL
,	NULL
O.	NULL
Marin	NULL
,	NULL
A.	NULL
Donella-Deana	NULL
,	NULL
and	NULL
L..	NULL
A.	NULL
Pinna	NULL
.	NULL

1996	NULL
.	NULL

SH2	NULL
domains	NULL
mediate	NULL
the	NULL
sequential	NULL
phosphorylation	NULL
of	NULL
HS1	NULL
protein	NULL
by	NULL
p72	NULL
Syk	NULL
and	NULL
Src-related	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Biochemistry	NULL
35:5327	NULL
.	NULL

Marengere	NULL
,	NULL
L.	NULL
E.	NULL
M.	NULL
,	NULL
P.	NULL
Waterhouse	NULL
,	NULL
G.	NULL
S.	NULL
Duncan	NULL
,	NULL
H.-W.	NULL
Mittrucker	NULL
,	NULL
G.-S.	NULL
Feng	NULL
,	NULL
and	NULL
T.	NULL
Mak	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
signaling	NULL
by	NULL
tyrosine	NULL
phosphatase	NULL
SYP	NULL
association	NULL
with	NULL
CTLA-4	NULL
.	NULL

Science	NULL
272:1170	NULL
.	NULL

Altevogt	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
Schreck	NULL
,	NULL
B.	NULL
Schraven	NULL
,	NULL
S.	NULL
Meuer	NULL
,	NULL
V.	NULL
Schirrmacher	NULL
,	NULL
and	NULL
A.	NULL
Mitsch	NULL
.	NULL

1989	NULL
.	NULL

Association	NULL
of	NULL
CD2	NULL
and	NULL
T200	NULL
(	NULL
CD45	NULL
)	NULL
in	NULL
mouse	NULL
T	NULL
lymphocytes	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

2:353	NULL
.	NULL

Schraven	NULL
,	NULL
B.	NULL
,	NULL
Y.	NULL
Samstag	NULL
,	NULL
P.	NULL
Altevogt	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Meuer	NULL
.	NULL

1990	NULL
.	NULL

Association	NULL
of	NULL
CD2	NULL
and	NULL
CD45	NULL
on	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Nature	NULL
345:71	NULL
.	NULL

Nishizuka	NULL
,	NULL
Y	NULL
.	NULL

1992	NULL
.	NULL

Intracellular	NULL
signaling	NULL
by	NULL
hydrolysis	NULL
of	NULL
phospholipids	NULL
and	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C.	NULL
Science	NULL
258:607	NULL
.	NULL

Gupta	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
Weiss	NULL
,	NULL
G.	NULL
Kumar	NULL
,	NULL
S.	NULL
Wang	NULL
,	NULL
and	NULL
A.	NULL
Nel	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
utilizes	NULL
Lok	NULL
,	NULL
Raf-1	NULL
,	NULL
and	NULL
Mek-1	NULL
for	NULL
activating	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:17349	NULL
.	NULL

Rao	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Hogan	NULL
.	NULL

1997	NULL
.	NULL

Transcription	NULL
factors	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
:	NULL
regulation	NULL
and	NULL
function	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15:707	NULL
.	NULL

Crabiree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
N.	NULL
A.	NULL
Clipstone	NULL
.	NULL

1994	NULL
.	NULL

Signal	NULL
transmission	NULL
between	NULL
the	NULL
plasma	NULL
membrane	NULL
and	NULL
nucleus	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

63:1045	NULL
.	NULL

Liu	NULL
,	NULL
K.-Q	NULL
.	NULL

,	NULL
S.	NULL
C.	NULL
Bunnell	NULL
,	NULL
C.	NULL
B.	NULL
Gurniak	NULL
,	NULL
and	NULL
L.	NULL
J.	NULL
Berg	NULL
.	NULL

1998	NULL
.	NULL

T	NULL
cell	NULL
receptor-initiated	NULL
calcium	NULL
release	NULL
is	NULL
uncoupled	NULL
from	NULL
capacitative	NULL
calcium	NULL
entry	NULL
in	NULL
itk-deficient	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187:1721	NULL
.	NULL

Jayaraman	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Ondria	NULL
,	NULL
E.	NULL
Ondriaova	NULL
,	NULL
and	NULL
A.	NULL
R.	NULL
Marks	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
inositol	NULL
1,4,5-trisphosphate	NULL
receptor	NULL
by	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Science	NULL
272:1492	NULL
.	NULL

Suzuki	NULL
,	NULL
Y.	NULL
,	NULL
C.	NULL
Demoliere	NULL
,	NULL
D.	NULL
Kitamura	NULL
,	NULL
H.	NULL
Takeshita	NULL
,	NULL
U.	NULL
Deuschle	NULL
,	NULL
and	NULL
T.	NULL
Watanabe	NULL
.	NULL

1997	NULL
.	NULL

HAX-1	NULL
,	NULL
a	NULL
novel	NULL
intracellular	NULL
protein	NULL
,	NULL
localized	NULL
on	NULL
mitochon-dria	NULL
,	NULL
directly	NULL
associates	NULL
with	NULL
HS1	NULL
,	NULL
a	NULL
substrate	NULL
of	NULL
Src	NULL
family	NULL
tyrosine	NULL
kinases	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:2736	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

